10.78false--12-31Q120192019-03-3110-Q0001038509400000falseNon-accelerated FilerPRUCO LIFE INSURANCE OF NEW JERSEYfalse129789200055400000400000400000400000400000400000003000000700000081360008181000200000010673000159290008000000100000000074460007446000
0001038509
2019-01-01
2019-03-31
0001038509
2019-05-09
0001038509
2018-12-31
0001038509
2019-03-31
0001038509
2018-01-01
2018-03-31
0001038509
us-gaap:ParentMember
2018-01-01
2018-03-31
0001038509
us-gaap:RetainedEarningsMember
2017-12-31
0001038509
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0001038509
us-gaap:AdditionalPaidInCapitalMember
2018-03-31
0001038509
us-gaap:CommonStockMember
2017-12-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:RetainedEarningsMember
2018-03-31
0001038509
us-gaap:ParentMember
2018-03-31
0001038509
cik1038509:AccountingStandardUpdate201802Member
us-gaap:RetainedEarningsMember
2018-03-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-12-31
0001038509
us-gaap:AccountingStandardsUpdate201601Member
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-03-31
0001038509
us-gaap:ParentMember
2017-12-31
0001038509
us-gaap:RetainedEarningsMember
2018-01-01
2018-03-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-03-31
0001038509
us-gaap:CommonStockMember
2018-03-31
0001038509
us-gaap:AccountingStandardsUpdate201601Member
us-gaap:ParentMember
2018-03-31
0001038509
us-gaap:AccountingStandardsUpdate201601Member
us-gaap:RetainedEarningsMember
2018-03-31
0001038509
cik1038509:AccountingStandardUpdate201802Member
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-03-31
0001038509
us-gaap:AdditionalPaidInCapitalMember
2018-01-01
2018-03-31
0001038509
us-gaap:CommonStockMember
2018-12-31
0001038509
us-gaap:RetainedEarningsMember
2019-01-01
2019-03-31
0001038509
us-gaap:RetainedEarningsMember
2018-12-31
0001038509
us-gaap:RetainedEarningsMember
2019-03-31
0001038509
us-gaap:ParentMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0001038509
us-gaap:ParentMember
2019-03-31
0001038509
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-03-31
0001038509
us-gaap:CommonStockMember
2019-03-31
0001038509
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ParentMember
2018-12-31
0001038509
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0001038509
2017-12-31
0001038509
2018-03-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2018-12-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
us-gaap:FinancingReceivables60To89DaysPastDueMember
2018-12-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
2018-12-31
0001038509
us-gaap:FinancingReceivables60To89DaysPastDueMember
2018-12-31
0001038509
us-gaap:CommercialLoanMember
2018-12-31
0001038509
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2018-12-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2018-12-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:FinancingReceivables30To59DaysPastDueMember
2018-12-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:FinancingReceivables60To89DaysPastDueMember
2018-12-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
us-gaap:FinancingReceivables30To59DaysPastDueMember
2018-12-31
0001038509
us-gaap:FinancingReceivables30To59DaysPastDueMember
2018-12-31
0001038509
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:PrivateEquityFundsDomesticMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:DomesticCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:PrivateEquityFundsForeignMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FixedMaturitiesMember
2018-01-01
2018-03-31
0001038509
cik1038509:TradingMember
us-gaap:FixedMaturitiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:LoansMember
2019-01-01
2019-03-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-01-01
2019-03-31
0001038509
us-gaap:PolicyLoansMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:OtherInvestmentsMember
2019-01-01
2019-03-31
0001038509
cik1038509:TradingMember
us-gaap:FixedMaturitiesMember
2019-01-01
2019-03-31
0001038509
cik1038509:ShortterminvestmentsandcashequivalentsMember
2019-01-01
2019-03-31
0001038509
cik1038509:ShortterminvestmentsandcashequivalentsMember
2018-01-01
2018-03-31
0001038509
us-gaap:LoansMember
2018-01-01
2018-03-31
0001038509
us-gaap:PolicyLoansMember
2019-01-01
2019-03-31
0001038509
us-gaap:OtherInvestmentsMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
2019-01-01
2019-03-31
0001038509
srt:PartnershipInterestMember
2018-01-01
2018-03-31
0001038509
us-gaap:DerivativeMember
2019-01-01
2019-03-31
0001038509
us-gaap:FixedMaturitiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:FixedMaturitiesMember
2019-01-01
2019-03-31
0001038509
us-gaap:DerivativeMember
2018-01-01
2018-03-31
0001038509
srt:PartnershipInterestMember
2019-01-01
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2018-12-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2018-12-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2018-12-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2018-12-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2019-03-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
us-gaap:Ltv80To100PercentMember
2019-03-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioLessThanOnePointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioZeroPercentToFortyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioGreaterThanTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSixtyPercentToSixtyNinePointNineNinePercentMember
2019-03-31
0001038509
cik1038509:DebtServiceCoverageRatioOnePointEightXToTwoPointZeroXMember
cik1038509:CommercialMortgageAndAgriculturalLoansMember
cik1038509:LoanToValueRatioSeventyPercentToSeventyNinePointNineNinePercentMember
2019-03-31
0001038509
us-gaap:FixedMaturitiesMember
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-03-31
0001038509
us-gaap:Maturity30To90DaysMember
2019-03-31
0001038509
stpr:TX
2019-03-31
0001038509
us-gaap:OtherIncomeMember
us-gaap:EquitySecuritiesMember
2019-01-01
2019-03-31
0001038509
us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember
2018-12-31
0001038509
us-gaap:OtherIncomeMember
us-gaap:EquitySecuritiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
srt:EuropeMember
2019-03-31
0001038509
cik1038509:NAICOtherThanHighorHighestQualityRatingMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
cik1038509:NAICHighorHighestQualityRatingMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:LoansMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2018-12-31
0001038509
cik1038509:NAICOtherThanHighorHighestQualityRatingMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
stpr:NY
2019-03-31
0001038509
cik1038509:NAICHighorHighestQualityRatingMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:LoansMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2019-03-31
0001038509
stpr:IL
2019-03-31
0001038509
us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember
2019-03-31
0001038509
us-gaap:FixedMaturitiesMember
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
us-gaap:PrivateEquityFundsMember
2019-03-31
0001038509
srt:PartnershipInterestMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:PrivateEquityFundsMember
2019-03-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:RealEstateInvestmentMember
2018-12-31
0001038509
cik1038509:InvestmentInSeparateAccountMember
2019-03-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:PrivateEquityFundsMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:RealEstateInvestmentMember
2019-03-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:HedgeFundsMember
2018-12-31
0001038509
cik1038509:InvestmentInSeparateAccountMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
us-gaap:HedgeFundsMember
2019-03-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
us-gaap:PrivateEquityFundsMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
us-gaap:RealEstateInvestmentMember
2018-12-31
0001038509
us-gaap:DerivativeMember
2019-03-31
0001038509
srt:PartnershipInterestMember
2019-03-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
2019-03-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
us-gaap:HedgeFundsMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:HedgeFundsMember
2019-03-31
0001038509
us-gaap:DerivativeMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
2018-12-31
0001038509
srt:PartnershipInterestMember
us-gaap:EquityMethodInvestmentsMember
us-gaap:RealEstateInvestmentMember
2019-03-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:OtherInvestmentsMember
2018-12-31
0001038509
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2019-03-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FixedMaturitiesMember
cik1038509:AccumulatedAllOtherOtherthanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:OtherAffiliatesMember
2018-12-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:FixedMaturitiesMember
cik1038509:AccumulatedAllOtherOtherthanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:OtherAffiliatesMember
2019-03-31
0001038509
us-gaap:OtherInvestmentsMember
2019-03-31
0001038509
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-12-31
0001038509
srt:HotelMember
2018-12-31
0001038509
srt:OtherPropertyMember
2019-03-31
0001038509
srt:OfficeBuildingMember
2019-03-31
0001038509
srt:OtherPropertyMember
2018-12-31
0001038509
cik1038509:AgriculturalPropertiesMember
2018-12-31
0001038509
srt:RetailSiteMember
2019-03-31
0001038509
srt:IndustrialPropertyMember
2018-12-31
0001038509
srt:OfficeBuildingMember
2018-12-31
0001038509
srt:HotelMember
2019-03-31
0001038509
srt:ApartmentBuildingMember
2019-03-31
0001038509
srt:IndustrialPropertyMember
2019-03-31
0001038509
us-gaap:CommercialLoanMember
2018-12-31
0001038509
cik1038509:AgriculturalPropertiesMember
2019-03-31
0001038509
srt:RetailSiteMember
2018-12-31
0001038509
us-gaap:CommercialLoanMember
2019-03-31
0001038509
srt:ApartmentBuildingMember
2018-12-31
0001038509
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FixedMaturitiesMember
2018-12-31
0001038509
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:PrivateEquityFundsForeignMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:DomesticCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:PrivateEquityFundsDomesticMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2018-12-31
0001038509
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:PrivateEquityFundsForeignMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:USTreasuryAndGovernmentMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:DomesticCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:PrivateEquityFundsDomesticMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:ForeignGovernmentDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:PrivateEquityFundsDomesticMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:ForeignCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:PrivateEquityFundsForeignMember
us-gaap:FixedMaturitiesMember
2019-03-31
0001038509
us-gaap:DomesticCorporateDebtSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:CommercialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:ResidentialMortgageBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:AssetBackedSecuritiesMember
us-gaap:FixedMaturitiesMember
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
2019-03-31
0001038509
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:AssetBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
2018-12-31
0001038509
us-gaap:DomesticCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:MaturityUpTo30DaysMember
2018-12-31
0001038509
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:MaturityUpTo30DaysMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityUpTo30DaysMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:MaturityUpTo30DaysMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityUpTo30DaysMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityUpTo30DaysMember
2019-03-31
0001038509
us-gaap:MaturityUpTo30DaysMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:DomesticCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
2019-03-31
0001038509
us-gaap:MaturityUpTo30DaysMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:ForeignCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:ForeignCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:MaturityOvernightAndOnDemandMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2019-03-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
2019-01-01
2019-03-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
2019-03-31
0001038509
us-gaap:CommercialLoanMember
2019-03-31
0001038509
2018-01-01
2018-12-31
0001038509
us-gaap:CommercialLoanMember
2019-01-01
2019-03-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
2018-01-01
2018-12-31
0001038509
us-gaap:CommercialLoanMember
2018-01-01
2018-12-31
0001038509
us-gaap:CommercialLoanMember
2017-12-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
2017-12-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:FinancingReceivables30To59DaysPastDueMember
2019-03-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
us-gaap:FinancingReceivables30To59DaysPastDueMember
2019-03-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2019-03-31
0001038509
cik1038509:AgriculturalPropertyLoansMember
us-gaap:FinancingReceivables60To89DaysPastDueMember
2019-03-31
0001038509
us-gaap:FinancingReceivables30To59DaysPastDueMember
2019-03-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:FinancingReceivables60To89DaysPastDueMember
2019-03-31
0001038509
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2019-03-31
0001038509
us-gaap:FinancingReceivables60To89DaysPastDueMember
2019-03-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember
2019-03-31
0001038509
us-gaap:Maturity30To90DaysMember
2018-12-31
0001038509
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember
2018-12-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:EmbeddedDerivativeFinancialInstrumentsMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:CreditRiskContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:InvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:EquityContractMember
us-gaap:NondesignatedMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:InterestRateContractMember
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:NondesignatedMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2018-12-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2018-12-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2018-12-31
0001038509
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2018-12-31
0001038509
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2018-12-31
0001038509
us-gaap:NondesignatedMember
2018-12-31
0001038509
us-gaap:CreditDefaultSwapMember
us-gaap:NondesignatedMember
2019-03-31
0001038509
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2019-03-31
0001038509
us-gaap:StockOptionMember
us-gaap:NondesignatedMember
2019-03-31
0001038509
us-gaap:InterestRateSwapMember
us-gaap:NondesignatedMember
2018-12-31
0001038509
us-gaap:CurrencySwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2018-12-31
0001038509
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2018-12-31
0001038509
us-gaap:CurrencySwapMember
us-gaap:NondesignatedMember
2019-03-31
0001038509
us-gaap:DesignatedAsHedgingInstrumentMember
2018-12-31
0001038509
us-gaap:CurrencySwapMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-03-31
0001038509
us-gaap:StockOptionMember
us-gaap:NondesignatedMember
2018-12-31
0001038509
us-gaap:DesignatedAsHedgingInstrumentMember
2019-03-31
0001038509
us-gaap:NondesignatedMember
2019-03-31
0001038509
us-gaap:ForeignExchangeForwardMember
us-gaap:NondesignatedMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
cik1038509:SeparateAccountAssetsMember
2019-03-31
0001038509
cik1038509:InternalPricingMember
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
cik1038509:FuturePolicyBenefitsMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-01-01
2019-03-31
0001038509
us-gaap:OtherInvestmentsMember
2018-12-31
0001038509
cik1038509:SeparateAccountAssetsMember
2018-12-31
0001038509
us-gaap:OtherInvestmentsMember
2019-03-31
0001038509
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
cik1038509:FuturePolicyBenefitsMember
2019-01-01
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
2019-01-01
2019-03-31
0001038509
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
2019-01-01
2019-03-31
0001038509
cik1038509:InternalPricingMember
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
cik1038509:FuturePolicyBenefitsMember
us-gaap:IncomeApproachValuationTechniqueMember
2019-01-01
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:OtherIncomeMember
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:EquitySecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
cik1038509:NetInvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2019-01-01
2019-03-31
0001038509
us-gaap:EquitySecuritiesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2019-01-01
2019-03-31
0001038509
us-gaap:EquitySecuritiesMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2019-01-01
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
us-gaap:EquitySecuritiesMember
cik1038509:NetInvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
cik1038509:NetInvestmentIncomeMember
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
us-gaap:OtherIncomeMember
2019-01-01
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
cik1038509:NetInvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
us-gaap:GainLossOnInvestmentsMember1
2019-01-01
2019-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
cik1038509:NetInvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2019-01-01
2019-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2019-01-01
2019-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
cik1038509:NetInvestmentIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
cik1038509:NetInvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
cik1038509:NetInvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2018-01-01
2018-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2018-01-01
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2018-01-01
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
cik1038509:NetInvestmentIncomeMember
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
cik1038509:NetInvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
cik1038509:NetInvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:GainLossOnInvestmentsMember1
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:OtherIncomeMember
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
cik1038509:NetInvestmentIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
us-gaap:OtherIncomeMember
2018-01-01
2018-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
cik1038509:IncludedinothercomprehensiveincomelossMember
2018-01-01
2018-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
us-gaap:GainLossOnInvestmentsMember1
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
2018-12-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
2019-01-01
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2019-01-01
2019-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2019-01-01
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2018-12-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:StructuredFinanceMember
us-gaap:AvailableforsaleSecuritiesMember
2019-01-01
2019-03-31
0001038509
us-gaap:EquitySecuritiesMember
2019-01-01
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2019-01-01
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:AvailableforsaleSecuritiesMember
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:StructuredFinanceMember
us-gaap:AvailableforsaleSecuritiesMember
2019-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:StructuredFinanceMember
us-gaap:AvailableforsaleSecuritiesMember
2018-12-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
2019-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
2018-12-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:AvailableforsaleSecuritiesMember
2018-12-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2018-12-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2019-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2018-12-31
0001038509
us-gaap:EquitySecuritiesMember
2019-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2019-03-31
0001038509
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-03-31
0001038509
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001038509
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2018-12-31
0001038509
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2019-03-31
0001038509
us-gaap:OtherInvestmentsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-03-31
0001038509
cik1038509:FairValueLiabilityMeasuredOnRecurringBasisLiabilityForPayablesToParentAndAffiliatesMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2019-03-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2019-03-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2019-03-31
0001038509
cik1038509:InternalPricingMember
srt:MinimumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:IncomeApproachValuationTechniqueMember
2018-01-01
2018-12-31
0001038509
cik1038509:InternalPricingMember
srt:MinimumMember
us-gaap:FairValueInputsLevel3Member
cik1038509:FuturePolicyBenefitsMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-01-01
2018-12-31
0001038509
cik1038509:InternalPricingMember
srt:MaximumMember
us-gaap:FairValueInputsLevel3Member
cik1038509:FuturePolicyBenefitsMember
us-gaap:IncomeApproachValuationTechniqueMember
2018-01-01
2018-12-31
0001038509
cik1038509:InternalPricingMember
srt:WeightedAverageMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:IncomeApproachValuationTechniqueMember
2018-01-01
2018-12-31
0001038509
cik1038509:InternalPricingMember
srt:MaximumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:IncomeApproachValuationTechniqueMember
2018-01-01
2018-12-31
0001038509
cik1038509:InternalPricingMember
us-gaap:FairValueInputsLevel3Member
cik1038509:FuturePolicyBenefitsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
cik1038509:InternalPricingMember
us-gaap:ReinsuranceRecoverableMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
cik1038509:InternalPricingMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2018-12-31
0001038509
cik1038509:FairValueLiabilityMeasuredOnRecurringBasisLiabilityForPayablesToParentAndAffiliatesMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsDomesticMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2018-12-31
0001038509
us-gaap:OtherInvestmentsMember
us-gaap:FairValueMeasurementsRecurringMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USStatesAndPoliticalSubdivisionsMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:USTreasuryAndGovernmentMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:CommercialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ResidentialMortgageBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:DomesticCorporateDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:PrivateEquityFundsForeignMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel2Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:AssetBackedSecuritiesMember
2018-12-31
0001038509
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
us-gaap:ForeignGovernmentDebtSecuritiesMember
2018-12-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
2018-01-01
2018-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2018-01-01
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:AvailableforsaleSecuritiesMember
2017-12-31
0001038509
us-gaap:EquitySecuritiesMember
2018-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2017-12-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:StructuredFinanceMember
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:AvailableforsaleSecuritiesMember
2018-01-01
2018-03-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2018-01-01
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
2018-01-01
2018-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2018-01-01
2018-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:StructuredFinanceMember
us-gaap:AvailableforsaleSecuritiesMember
2018-03-31
0001038509
us-gaap:ReinsuranceRecoverableMember
2018-03-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:AvailableforsaleSecuritiesMember
2018-03-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2018-03-31
0001038509
us-gaap:EquitySecuritiesMember
2017-12-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2018-03-31
0001038509
cik1038509:ReceivablesFromParentsAndAffiliatesMember
2017-12-31
0001038509
cik1038509:PolicyholdersAccountBalancesMember
2017-12-31
0001038509
us-gaap:DebtSecuritiesMember
us-gaap:StructuredFinanceMember
us-gaap:AvailableforsaleSecuritiesMember
2017-12-31
0001038509
cik1038509:FuturePolicyBenefitsMember
2017-12-31
0001038509
cik1038509:InternalPricingMember
srt:WeightedAverageMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:IncomeApproachValuationTechniqueMember
2019-01-01
2019-03-31
0001038509
cik1038509:InternalPricingMember
us-gaap:FairValueInputsLevel3Member
cik1038509:FuturePolicyBenefitsMember
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
cik1038509:InternalPricingMember
srt:MinimumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:IncomeApproachValuationTechniqueMember
2019-01-01
2019-03-31
0001038509
cik1038509:InternalPricingMember
srt:MaximumMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:IncomeApproachValuationTechniqueMember
2019-01-01
2019-03-31
0001038509
cik1038509:InternalPricingMember
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
cik1038509:InternalPricingMember
us-gaap:ReinsuranceRecoverableMember
us-gaap:FairValueInputsLevel3Member
us-gaap:FairValueMeasurementsRecurringMember
2019-03-31
0001038509
2017-06-30
0001038509
srt:AffiliatedEntityMember
cik1038509:TermReMember
2014-01-01
2014-01-01
0001038509
cik1038509:UnaffiliatedMember
2018-01-01
2018-03-31
0001038509
srt:AffiliatedEntityMember
cik1038509:ParTermMember
2010-01-01
2013-12-31
0001038509
srt:AffiliatedEntityMember
cik1038509:ParuMember
2012-07-01
2012-07-01
0001038509
cik1038509:UnaffiliatedMember
2019-01-01
2019-03-31
0001038509
srt:AffiliatedEntityMember
cik1038509:ParccMember
2009-12-31
2009-12-31
0001038509
srt:AffiliatedEntityMember
cik1038509:DARTMember
2018-01-01
2018-01-01
0001038509
cik1038509:ItemsEffectedByReinsuranceMember
2019-03-31
0001038509
cik1038509:ItemsEffectedByReinsuranceMember
2018-12-31
0001038509
cik1038509:TermReMember
2019-03-31
0001038509
cik1038509:PrucoLifeMember
2019-03-31
0001038509
cik1038509:DARTMember
2019-03-31
0001038509
cik1038509:UnaffiliatedMember
2019-03-31
0001038509
cik1038509:ParccMember
2018-12-31
0001038509
cik1038509:UnaffiliatedMember
2018-12-31
0001038509
cik1038509:TermReMember
2018-12-31
0001038509
cik1038509:ParTermMember
2018-12-31
0001038509
cik1038509:PrudentialInsuranceMember
2018-12-31
0001038509
cik1038509:ParuMember
2019-03-31
0001038509
cik1038509:ParuMember
2018-12-31
0001038509
cik1038509:PrudentialInsuranceMember
2019-03-31
0001038509
cik1038509:ParccMember
2019-03-31
0001038509
cik1038509:ParTermMember
2019-03-31
0001038509
cik1038509:PrucoLifeMember
2018-12-31
0001038509
cik1038509:DARTMember
2018-12-31
0001038509
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-03-31
0001038509
us-gaap:AccumulatedTranslationAdjustmentMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedTranslationAdjustmentMember
2019-03-31
0001038509
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
0001038509
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:DeferredCostsPolicyAcquisitionAndSalesInducementsAndValuationOfBusinessAcquiredPreTaxMember
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:PolicyholdersAccountBalancesPreTaxMember
2019-01-01
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:PolicyholdersAccountBalancesPreTaxMember
2018-12-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-01-01
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:PolicyholdersAccountBalancesPreTaxMember
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:DeferredCostsPolicyAcquisitionAndSalesInducementsAndValuationOfBusinessAcquiredPreTaxMember
2019-01-01
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:AccumulatedNetUnrealizedInvestmentGainLossPreTaxMember
2019-01-01
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:DeferredIncomeTaxLiabilityBenefitMember
2019-01-01
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:AccumulatedNetUnrealizedInvestmentGainLossPreTaxMember
2018-12-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:DeferredIncomeTaxLiabilityBenefitMember
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:DeferredCostsPolicyAcquisitionAndSalesInducementsAndValuationOfBusinessAcquiredPreTaxMember
2018-12-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:AccumulatedNetUnrealizedInvestmentGainLossPreTaxMember
2019-03-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
cik1038509:DeferredIncomeTaxLiabilityBenefitMember
2018-12-31
0001038509
cik1038509:OtherNetUnrealizedInvestmentGainsAndLossesMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-03-31
0001038509
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-01-01
2018-03-31
0001038509
cik1038509:AccountingStandardUpdate201802Member
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-03-31
0001038509
us-gaap:AccumulatedTranslationAdjustmentMember
2018-03-31
0001038509
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-03-31
0001038509
us-gaap:AccumulatedTranslationAdjustmentMember
2018-01-01
2018-03-31
0001038509
us-gaap:AccountingStandardsUpdate201601Member
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-03-31
0001038509
us-gaap:AccountingStandardsUpdate201601Member
us-gaap:AccumulatedTranslationAdjustmentMember
2018-03-31
0001038509
us-gaap:AccumulatedTranslationAdjustmentMember
2017-12-31
0001038509
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-12-31
0001038509
cik1038509:AccountingStandardUpdate201802Member
us-gaap:AccumulatedTranslationAdjustmentMember
2018-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-03-31
0001038509
us-gaap:CashFlowHedgingMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2017-12-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:AccumulatedNetUnrealizedInvestmentGainLossPreTaxMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:DeferredCostsPolicyAcquisitionAndSalesInducementsAndValuationOfBusinessAcquiredPreTaxMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:DeferredIncomeTaxLiabilityBenefitMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:PolicyholdersAccountBalancesPreTaxMember
2019-01-01
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:DeferredIncomeTaxLiabilityBenefitMember
2018-12-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:DeferredIncomeTaxLiabilityBenefitMember
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:DeferredCostsPolicyAcquisitionAndSalesInducementsAndValuationOfBusinessAcquiredPreTaxMember
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:AccumulatedNetUnrealizedInvestmentGainLossPreTaxMember
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:PolicyholdersAccountBalancesPreTaxMember
2018-12-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:AccumulatedNetUnrealizedInvestmentGainLossPreTaxMember
2018-12-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:PolicyholdersAccountBalancesPreTaxMember
2019-03-31
0001038509
us-gaap:AccumulatedOtherThanTemporaryImpairmentMember
cik1038509:DeferredCostsPolicyAcquisitionAndSalesInducementsAndValuationOfBusinessAcquiredPreTaxMember
2018-12-31
0001038509
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-01-01
2019-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-01-01
2018-03-31
0001038509
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-03-31
0001038509
us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0001038509
us-gaap:SubsidiaryOfCommonParentMember
2019-01-01
2019-03-31
0001038509
us-gaap:CorporateJointVentureMember
2018-12-31
0001038509
cik1038509:PrudentialInsuranceandPrudentialFInancialMember
2018-12-31
0001038509
cik1038509:PGIMMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
cik1038509:PrudentialAnnuitiesDistributorsMember
srt:AffiliatedEntityMember
2018-01-01
2018-03-31
0001038509
srt:ParentCompanyMember
2019-01-01
2019-03-31
0001038509
cik1038509:PrudentialInsuranceandPrudentialFInancialMember
2019-03-31
0001038509
us-gaap:SubsidiaryOfCommonParentMember
2018-01-01
2018-03-31
0001038509
us-gaap:CorporateJointVentureMember
2019-03-31
0001038509
cik1038509:PrudentialAnnuitiesDistributorsMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
cik1038509:PGIMMember
srt:AffiliatedEntityMember
2018-01-01
2018-03-31
0001038509
us-gaap:CorporateJointVentureMember
2018-01-01
2018-03-31
0001038509
cik1038509:PrudentialInsuranceandPrudentialFInancialMember
2019-01-01
2019-03-31
0001038509
us-gaap:CorporateJointVentureMember
2019-01-01
2019-03-31
0001038509
cik1038509:PGIMInvestmentsLLCMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
cik1038509:ASTISIandPGIMInvestmentsMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
srt:MinimumMember
cik1038509:U.S.DollarfloatingratenotesMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
cik1038509:U.S.DollarfloatingratenotesMember
srt:AffiliatedEntityMember
2019-03-31
0001038509
cik1038509:U.S.DollarfixedratenotesMember
srt:AffiliatedEntityMember
2018-12-31
0001038509
srt:AffiliatedEntityMember
2018-12-31
0001038509
srt:MaximumMember
cik1038509:U.S.DollarfixedratenotesMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
srt:MinimumMember
cik1038509:U.S.DollarfixedratenotesMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
cik1038509:U.S.DollarfloatingratenotesMember
srt:AffiliatedEntityMember
2018-12-31
0001038509
srt:MaximumMember
cik1038509:U.S.DollarfloatingratenotesMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
cik1038509:U.S.DollarfixedratenotesMember
srt:AffiliatedEntityMember
2019-03-31
0001038509
srt:AffiliatedEntityMember
2019-03-31
0001038509
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
srt:AffiliatedEntityMember
2018-01-01
2018-03-31
0001038509
cik1038509:GibraltarUniversalLifeReMember
srt:AffiliatedEntityMember
2019-03-31
0001038509
cik1038509:GibraltarUniversalLifeReMember
srt:AffiliatedEntityMember
2019-01-01
2019-03-31
0001038509
cik1038509:PGIMInvestmentsLLCMember
srt:AffiliatedEntityMember
2018-01-01
2018-03-31
0001038509
srt:ParentCompanyMember
2018-01-01
2018-03-31
0001038509
cik1038509:ASTISIandPGIMInvestmentsMember
srt:AffiliatedEntityMember
2018-01-01
2018-03-31
0001038509
cik1038509:PrudentialInsuranceandPrudentialFInancialMember
2018-01-01
2018-03-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:CommitmentsMember
2018-12-31
0001038509
us-gaap:InvestmentsMember
us-gaap:CommitmentsMember
2018-12-31
0001038509
us-gaap:InvestmentsMember
us-gaap:CommitmentsMember
2019-03-31
0001038509
us-gaap:CommercialLoanMember
us-gaap:CommitmentsMember
2019-03-31
xbrli:pure
iso4217:USD
xbrli:shares
cik1038509:subsidiary
xbrli:shares
iso4217:USD
cik1038509:policy
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 10-Q
________________________________________
|
| |
ý
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2019
OR
|
| |
¨
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Transition Period from to
Commission file number 333-18053
____________________________________________________________
Pruco Life Insurance Company of New Jersey
(Exact name of Registrant as specified in its charter)
|
| | |
New Jersey | | 22-2426091 |
(State or other jurisdiction of incorporation or organization) | | (IRS Employer Identification No.) |
213 Washington Street
Newark, New Jersey 07102
|
|
(973) 802-6000 |
(Address and Telephone Number of Registrant’s Principal Executive Offices) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of the Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer", "accelerated filer", "smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
| | | |
Large accelerated filer | ¨ | Accelerated filer | ¨ |
Non-accelerated filer | x | Smaller reporting company | ¨ |
| | Emerging growth company | ¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
|
| | |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered |
Not Applicable | Not Applicable | Not Applicable |
As of May 9, 2019, 400,000 shares of the registrant’s Common Stock (par value $5) were outstanding. As of such date, Pruco Life Insurance Company, an Arizona corporation, owned all of the registrant’s Common Stock.
Pruco Life Insurance Company of New Jersey meets the conditions set
forth in General Instruction (H) (1) (a) and (b) on Form 10-Q and
is therefore filing this Form 10-Q in the reduced disclosure format.
TABLE OF CONTENTS
|
| | |
| | Page Number |
| |
| | |
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 2. | | |
| | |
Item 3. | | |
| | |
Item 4. | | |
| | |
| |
| | |
Item 1. | | |
| | |
Item 1A. | | |
| | |
Item 6. | | |
| | |
| |
FORWARD-LOOKING STATEMENTS
Certain of the statements included in this Quarterly Report on Form 10-Q, including but not limited to those in Management’s Discussion and Analysis of Financial Condition and Results of Operations, constitute forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “expects,” “believes,” “anticipates,” “includes,” “plans,” “assumes,” “estimates,” “projects,” “intends,” “should,” “will,” “shall” or variations of such words are generally part of forward-looking statements. Forward-looking statements are made based on management’s current expectations and beliefs concerning future developments and their potential effects upon Pruco Life Insurance Company of New Jersey and its subsidiary. There can be no assurance that future developments affecting Pruco Life Insurance Company of New Jersey and its subsidiary will be those anticipated by management. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties, and there are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements, including, among others: (1) losses on investments or financial contracts due to deterioration in credit quality or value, or counterparty default; (2) losses on insurance products due to mortality experience or policyholder behavior experience that differs significantly from our expectations when we price our products; (3) changes in interest rates and equity prices that may (a) adversely impact the profitability of our products, the value of separate accounts supporting these products or the value of assets we manage, (b) result in losses on derivatives we use to hedge risk or increase collateral posting requirements and (c) limit opportunities to invest at appropriate returns; (4) guarantees within certain of our products which are market sensitive and may decrease our earnings or increase the volatility of our results of operations or financial position; (5) liquidity needs resulting from (a) derivative collateral market exposure, (b) asset/liability mismatches, (c) the lack of available funding in the financial markets or (d) unexpected cash demands due to severe mortality calamity or lapse events; (6) financial or customer losses, or regulatory and legal actions, due to inadequate or failed processes or systems, external events and human error or misconduct such as (a) disruption of our systems and data, (b) an information security breach, (c) a failure to protect the privacy of sensitive data or (d) reliance on third-parties; (7) changes in the regulatory landscape, including related to (a) financial sector regulatory reform, (b) changes in tax laws, (c) fiduciary rules and other standards of care, (d) state insurance laws and developments regarding group-wide supervision, capital and reserves, and (e) privacy and cybersecurity regulation; (8) technological changes which may adversely impact companies in our investment portfolio or cause insurance experience to deviate from our assumptions; (9) ratings downgrades; (10) market conditions that may adversely affect the sales or persistency of our products; (11) competition; and (12) reputational damage. Pruco Life Insurance Company of New Jersey does not intend, and is under no obligation, to update any particular forward-looking statement included in this document. See “Risk Factors” included in the Annual Report on Form 10-K for the year ended December 31, 2018 for discussion of certain risks relating to our business and investment in our securities.
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Unaudited Interim Statements of Financial Position
March 31, 2019 and December 31, 2018 (in thousands, except share amounts)
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
ASSETS | | | |
Fixed maturities available for sale, at fair value (amortized cost: 2019 – $1,350,057; 2018 – $1,297,892) | $ | 1,378,474 |
| | $ | 1,277,824 |
|
Fixed Maturities, Trading, at Fair Value (amortized cost: 2019 – $7,446; 2018 – $7,446) | 6,182 |
| | 5,770 |
|
Equity securities, at fair value (cost: 2019 – $8,181; 2018 – $8,136) | 10,127 |
| | 9,870 |
|
Policy loans | 207,649 |
| | 206,448 |
|
Commercial mortgage and other loans | 117,958 |
| | 118,636 |
|
Other invested assets (includes $15,929 and $10,673 measured at fair value at March 31, 2019 and December 31, 2018, respectively) | 67,458 |
| | 58,413 |
|
Total investments | 1,787,848 |
| | 1,676,961 |
|
Cash and cash equivalents | 47,955 |
| | 70,441 |
|
Deferred policy acquisition costs | 166,533 |
| | 165,478 |
|
Accrued investment income | 18,133 |
| | 17,764 |
|
Reinsurance recoverables | 2,834,073 |
| | 2,723,518 |
|
Receivables from parent and affiliates | 33,206 |
| | 40,388 |
|
Income taxes receivable | 8,872 |
| | 19,134 |
|
Other assets | 25,137 |
| | 23,973 |
|
Separate account assets | 14,631,038 |
| | 13,382,345 |
|
TOTAL ASSETS | $ | 19,552,795 |
| | $ | 18,120,002 |
|
LIABILITIES AND EQUITY | | | |
LIABILITIES | | | |
Policyholders’ account balances | $ | 2,350,215 |
| | $ | 2,314,958 |
|
Future policy benefits | 1,933,169 |
| | 1,820,092 |
|
Cash collateral for loaned securities | 3,087 |
| | 2,702 |
|
Payables to parent and affiliates | 23,622 |
| | 20,413 |
|
Other liabilities | 119,922 |
| | 134,771 |
|
Separate account liabilities | 14,631,038 |
| | 13,382,345 |
|
TOTAL LIABILITIES | 19,061,053 |
| | 17,675,281 |
|
COMMITMENTS AND CONTINGENT LIABILITIES (See Note 10) |
| |
|
EQUITY | | | |
Common stock ($5 par value; 400,000 shares authorized, issued and outstanding) | 2,000 |
| | 2,000 |
|
Additional paid-in capital | 213,261 |
| | 213,261 |
|
Retained earnings | 254,036 |
| | 243,827 |
|
Accumulated other comprehensive income (loss) | 22,445 |
| | (14,367 | ) |
TOTAL EQUITY | 491,742 |
| | 444,721 |
|
TOTAL LIABILITIES AND EQUITY | $ | 19,552,795 |
| | $ | 18,120,002 |
|
See Notes to Unaudited Interim Financial Statements
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Unaudited Interim Statements of Operations and Comprehensive Income (Loss)
Three Months Ended March 31, 2019 and 2018 (in thousands)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
REVENUES | | | |
Premiums | $ | 3,338 |
| | $ | 2,497 |
|
Policy charges and fee income | 19,849 |
| | 24,814 |
|
Net investment income | 18,741 |
| | 16,549 |
|
Asset administration fees | 1,343 |
| | 1,306 |
|
Other income | 1,314 |
| | 371 |
|
Realized investment gains (losses), net: | | | |
Other-than-temporary impairments on fixed maturity securities | (2,784 | ) | | 0 |
|
Other-than-temporary impairments on fixed maturity securities transferred to other comprehensive income | (379 | ) | | 0 |
|
Other realized investment gains (losses), net | (2,947 | ) | | (3,931 | ) |
Total realized investment gains (losses), net | (6,110 | ) | | (3,931 | ) |
TOTAL REVENUES | 38,475 |
| | 41,606 |
|
BENEFITS AND EXPENSES | | | |
Policyholders’ benefits | 9,977 |
| | 8,552 |
|
Interest credited to policyholders’ account balances | 9,053 |
| | 8,564 |
|
Amortization of deferred policy acquisition costs | 1,225 |
| | 5,967 |
|
General, administrative and other expenses | 7,098 |
| | 7,756 |
|
TOTAL BENEFITS AND EXPENSES | 27,353 |
| | 30,839 |
|
INCOME (LOSS) FROM OPERATIONS BEFORE INCOME TAXES | 11,122 |
| | 10,767 |
|
Income tax expense (benefit) | 577 |
| | 747 |
|
NET INCOME (LOSS) | $ | 10,545 |
| | $ | 10,020 |
|
Other comprehensive income (loss), before tax: | | | |
Foreign currency translation adjustments | 0 |
| | (235 | ) |
Net unrealized investment gains (losses) | 46,598 |
| | (36,561 | ) |
Total | 46,598 |
| | (36,796 | ) |
Less: Income tax expense (benefit) related to other comprehensive income (loss) | 9,786 |
| | (7,728 | ) |
Other comprehensive income (loss), net of tax | 36,812 |
| | (29,068 | ) |
COMPREHENSIVE INCOME (LOSS) | $ | 47,357 |
| | $ | (19,048 | ) |
See Notes to Unaudited Interim Financial Statements
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Unaudited Interim Statements of Equity
Three Months Ended March 31, 2019 and 2018 (in thousands)
|
| | | | | | | | | | | | | | | | | | | |
| Common Stock | | Additional Paid-in Capital | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Total Equity |
Balance, December 31, 2018 | $ | 2,000 |
| | $ | 213,261 |
| | $ | 243,827 |
| | $ | (14,367 | ) | | $ | 444,721 |
|
Cumulative effect of adoption of accounting changes(1) | | | | | (336 | ) | | 0 |
| | (336 | ) |
Contributed capital | | | 0 |
| | | | | | 0 |
|
Comprehensive income (loss): | | | | | | | | | |
Net income (loss) | | | | | 10,545 |
| | | | 10,545 |
|
Other comprehensive income (loss), net of tax | | | | | | | 36,812 |
| | 36,812 |
|
Total comprehensive income (loss) | | | | | | | | | 47,357 |
|
Balance, March 31, 2019 | $ | 2,000 |
| | $ | 213,261 |
| | $ | 254,036 |
| | $ | 22,445 |
| | $ | 491,742 |
|
|
| | | | | | | | | | | | | | | | | | | |
| Common Stock | | Additional Paid-in Capital | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Total Equity |
Balance, December 31, 2017 | $ | 2,000 |
| | $ | 211,961 |
| | $ | 218,067 |
| | $ | 34,330 |
| | $ | 466,358 |
|
Cumulative effect of adoption of ASU 2016-01 | | | | | 372 |
| | (175 | ) | | 197 |
|
Cumulative effect of adoption of ASU 2018-02 | | | | | (5,893 | ) | | 5,893 |
| | |
Contributed capital | | | 1,300 |
| | | | | | 1,300 |
|
Comprehensive income (loss): | | | | | | | | | |
Net income (loss) | | | | | 10,020 |
| | | | 10,020 |
|
Other comprehensive income (loss), net of tax | | | | | | | (29,068 | ) | | (29,068 | ) |
Total comprehensive income (loss) | | | | | | | | | (19,048 | ) |
Balance, March 31, 2018 | $ | 2,000 |
| | $ | 213,261 |
| | $ | 222,566 |
| | $ | 10,980 |
| | $ | 448,807 |
|
| |
| Includes the impact from the adoption of ASUs 2017-08 and 2017-12. See Note 2. |
See Notes to Unaudited Interim Financial Statements
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY
Unaudited Interim Statements of Cash Flows
Three Months Ended March 31, 2019 and 2018 (in thousands)
|
| | | | | | | |
| 2019 | | 2018 |
CASH FLOWS FROM OPERATING ACTIVITIES: | | | |
Net income (loss) | $ | 10,545 |
| | $ | 10,020 |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | |
Policy charges and fee income | (5,763 | ) | | (7,442 | ) |
Interest credited to policyholders’ account balances | 9,053 |
| | 8,564 |
|
Realized investment (gains) losses, net | 6,110 |
| | 3,931 |
|
Amortization and other non-cash items | (3,644 | ) | | (1,429 | ) |
Change in: | | | |
Future policy benefits | 37,994 |
| | 56,784 |
|
Reinsurance recoverables | (29,362 | ) | | (47,524 | ) |
Accrued investment income | (369 | ) | | (638 | ) |
Net payables to/receivables from parent and affiliates | 4,328 |
| | 3,099 |
|
Deferred policy acquisition costs | (5,032 | ) | | (1,751 | ) |
Income taxes | 566 |
| | 735 |
|
Derivatives, net | (596 | ) | | (3,711 | ) |
Other, net | (15,723 | ) | | (1,824 | ) |
Cash flows from (used in) operating activities | 8,107 |
| | 18,814 |
|
CASH FLOWS FROM INVESTING ACTIVITIES: | | | |
Proceeds from the sale/maturity/prepayment of: | | | |
Fixed maturities, available-for-sale | 5,559 |
| | 8,045 |
|
Equity securities | 5 |
| | 0 |
|
Policy loans | 6,130 |
| | 5,710 |
|
Ceded policy loans | (489 | ) | | (286 | ) |
Commercial mortgage and other loans | 899 |
| | 597 |
|
Other invested assets | 259 |
| | 179 |
|
Payments for the purchase/origination of: | | | |
Fixed maturities, available-for-sale | (61,694 | ) | | (49,327 | ) |
Equity securities | (50 | ) | | (2,000 | ) |
Policy loans | (5,238 | ) | | (6,450 | ) |
Ceded policy loans | 453 |
| | 643 |
|
Commercial mortgage and other loans | 0 |
| | (1,595 | ) |
Other invested assets | (2,898 | ) | | (1,265 | ) |
Notes receivable from parent and affiliates, net | 6,068 |
| | 155 |
|
Derivatives, net | 10 |
| | (90 | ) |
Other, net | (62 | ) | | (139 | ) |
Cash flows from (used in) investing activities | (51,048 | ) | | (45,823 | ) |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | |
Policyholders’ account deposits | 137,408 |
| | 123,760 |
|
Ceded policyholders’ account deposits | (84,766 | ) | | (81,829 | ) |
Policyholders’ account withdrawals | (77,259 | ) | | (62,539 | ) |
Ceded policyholders’ account withdrawals | 55,068 |
| | 39,776 |
|
Net change in securities sold under agreement to repurchase and cash collateral for loaned securities | 385 |
| | (10,870 | ) |
Net change in financing arrangements (maturities 90 days or less) | 0 |
| | 80 |
|
Drafts outstanding | (10,381 | ) | | (169 | ) |
Cash flows from (used in) financing activities | 20,455 |
| | 8,209 |
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (22,486 | ) | | (18,800 | ) |
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 70,441 |
| | 44,618 |
|
CASH AND CASH EQUIVALENTS, END OF PERIOD | $ | 47,955 |
| | $ | 25,818 |
|
Significant Non-Cash Transactions
There were no significant non-cash transactions for the three months ended March 31, 2019 and 2018.
See Notes to Unaudited Interim Financial Statements
|
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements |
1. BUSINESS AND BASIS OF PRESENTATION
Pruco Life Insurance Company of New Jersey ("PLNJ") is a wholly-owned subsidiary of Pruco Life Insurance Company (“Pruco Life”), which in turn is a wholly-owned subsidiary of The Prudential Insurance Company of America (“Prudential Insurance”). Prudential Insurance is a direct wholly-owned subsidiary of Prudential Financial, Inc. (“Prudential Financial”). PLNJ is a stock life insurance company organized in 1982 under the laws of the State of New Jersey. It is licensed to sell life insurance and annuities in New Jersey and New York only, and sells such products primarily through affiliated and unaffiliated distributors.
PLNJ had one subsidiary, formed in 2009 for the purpose of holding certain commercial mortgage loans and other investments which ceased operations and was dissolved as of December 31, 2018.
Basis of Presentation
The Unaudited Interim Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Intercompany balances and transactions have been eliminated.
In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
The most significant estimates include those used in determining deferred policy acquisition costs ("DAC") and related amortization; amortization of deferred sales inducements ("DSI"); valuation of investments including derivatives and the recognition of other-than-temporary impairments (“OTTI”); future policy benefits including guarantees; reinsurance recoverables; provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters.
Reclassifications
Certain amounts in prior periods have been reclassified to conform to the current period presentation.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
2. SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS
Recent Accounting Pronouncements
Changes to U.S. GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of Accounting Standards Updates ("ASU") to the FASB Accounting Standards Codification. The Company considers the applicability and impact of all ASU. ASU listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of the date of this filing. ASU not listed below were assessed and determined to be either not applicable or not material.
ASU adopted during the three months ended March 31, 2019.
|
| | | | | | |
Standard | | Description | | Effective date and method of adoption | | Effect on the financial statements or other significant matters |
ASU 2017-08, Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) Premium Amortization on Purchased Callable Debt Securities | | This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date.
| | January 1, 2019 using the modified retrospective method which included cumulative-effect adjustment on the balance sheet as of the beginning of the fiscal year of adoption. | | Adoption of the ASU did not have a significant impact on the Company’s Financial Statements and Notes to the Financial Statements. The impact of the cumulative-effect adjustment to retained earnings was immaterial. |
ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities
| | This ASU makes targeted changes to the existing hedge accounting model to better portray the economics of an entity’s risk management activities and to simplify the use of hedge accounting. The ASU eliminates separate measurement and recording of hedge ineffectiveness. It requires entities to present the earnings effect of the hedging instrument in the same income statement line item in which the hedged item is reported and also requires expanded disclosures.
| | January 1, 2019 using the modified retrospective method which included cumulative-effect adjustment on the balance sheet as of the beginning of the fiscal year of adoption. | | Adoption of the ASU did not have a significant impact on the Company’s Financial Statements and Notes to the Financial Statements. The impact of the cumulative-effect adjustment to retained earnings and accumulated other comprehensive income (loss) ("AOCI") related to ineffectiveness of the hedge instruments outstanding at the date of the adoption was immaterial. See Note 4 for additional required disclosures. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
ASU issued but not yet adopted as of March 31, 2019 — ASU 2018-12
ASU 2018-12, Financial Services - Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts, was issued by the FASB on August 15, 2018 and is expected to have a significant impact on the Company’s Financial Statements and Notes to the Financial Statements. The ASU is effective January 1, 2021 (with early adoption permitted), and will impact, at least to some extent, the accounting and disclosure requirements for all long-duration insurance and investment contracts issued by the Company. Outlined below are four key areas of change, although there are other changes not noted below. In addition to the impacts to the balance sheet upon adoption, the Company also expects an impact to how earnings emerge thereafter. |
| | | | | | |
ASU 2018-12 Amended Topic | | Description | | Method of adoption | | Effect on the financial statements or other significant matters |
Cash flow assumptions used to measure the liability for future policy benefits for non-participating traditional and limited-pay insurance products | | Requires an entity to review, and if necessary, update the cash flow assumptions used to measure the liability for future policy benefits, for both changes in future assumptions and actual experience, at least annually using a retrospective update method with a cumulative catch-up adjustment recorded in a separate line item in the Statements of Operations. | | An entity may choose one of two adoption methods for the liability for future policy benefits: (1) a modified retrospective transition method whereby the entity will apply the amendments to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or (2) a full retrospective transition method. | | The options for method of adoption and the impacts of such methods are under assessment. |
Discount rate assumption used to measure the liability for future policy benefits for non-participating traditional and limited-pay insurance products | | Requires discount rate assumptions to be based on an upper-medium grade fixed income instrument yield and will be required to be updated each quarter with the impact recorded through Other Comprehensive Income ("OCI"). | | As noted above, an entity may choose either a modified retrospective transition method or full retrospective transition method for the liability for future policy benefits. Under either method, for balance sheet remeasurement purposes, the liability for future policy benefits will be remeasured using current discount rates as of the beginning of the earliest period presented with the impact recorded as a cumulative effect adjustment to AOCI. | | Upon adoption, under either transition method, there will be an adjustment to AOCI as a result of remeasuring in force contract liabilities using current upper-medium grade fixed income instrument yields. The adjustment upon adoption will largely reflect the difference between the discount rate locked-in at contract inception versus current discount rates at transition. The magnitude of such adjustment is currently being assessed. |
Amortization of DAC and other balances | | Requires DAC and other balances, such as unearned revenue reserves and DSI, to be amortized on a constant level basis over the expected term of the related contract, independent of expected profitability. | | An entity may apply one of two adoption methods: (1) a modified retrospective transition method whereby the entity will apply the amendments to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or (2) if an entity chooses a full retrospective transition method for its future policy benefits, as described above, it is required to also use a retrospective transition method for DAC and other balances. | | The options for method of adoption and the impacts of such methods are under assessment. Under the modified retrospective transition method, the Company would not expect a significant impact to the balance sheet, other than the impact of the removal of any related amounts in AOCI. |
Market Risk Benefits | | Requires an entity to measure all market risk benefits (e.g., living benefit and death benefit guarantees associated with variable annuities) at fair value with changes in value attributable to changes in an entity’s non-performance risk ("NPR") to be recognized in OCI. | | An entity will apply a retrospective transition method which will include a cumulative-effect adjustment on the balance sheet as of the earliest period presented. | | Upon adoption, the Company expects an impact to retained earnings for the difference between the fair value and carrying value of benefits not currently measured at fair value (e.g., guaranteed minimum death benefits on variable annuities) and an impact from reclassifying the cumulative effect of changes in NPR from retained earnings to AOCI. The magnitude of such adjustments is currently being assessed. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Other ASU issued but not yet adopted as of March 31, 2019
|
| | | | | | |
Standard | | Description | | Effective date and method of adoption | | Effect on the financial statements or other significant matters |
ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments | | This ASU provides a new current expected credit loss model to account for credit losses on certain financial assets and off-balance sheet exposures (e.g., loans held for investment, debt securities held to maturity, reinsurance receivables, net investments in leases and loan commitments). The model requires an entity to estimate lifetime credit losses related to such financial assets and exposures based on relevant information about past events, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The standard also modifies the current other-than-temporary impairment standard for available-for-sale debt securities to require the use of an allowance rather than a direct write down of the investment, and replaces existing standard for purchased credit deteriorated loans and debt securities. | | January 1, 2020 using the modified retrospective method which will include a cumulative-effect adjustment on the balance sheet as of the beginning of the fiscal year of adoption. However, prospective application is required for purchased credit deteriorated assets previously accounted for under ASU 310-30 and for debt securities for which an other-than-temporary-impairment was recognized prior to the date of adoption. Early adoption is permitted beginning January 1, 2019. | | The Company does not plan to early adopt this ASU and is currently assessing its impact on the Company’s Financial Statements and Notes to the Financial Statements. |
3. INVESTMENTS
Fixed Maturity Securities
The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
|
| | | | | | | | | | | | | | | | | | | |
| March 31, 2019 |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | OTTI in AOCI(3) |
| (in thousands) |
Fixed maturities, available-for-sale: | | | | | | | | | |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | 15,290 |
| | $ | 1,005 |
| | $ | 0 |
| | $ | 16,295 |
| | $ | 0 |
|
Obligations of U.S. states and their political subdivisions | 120,531 |
| | 5,315 |
| | 8 |
| | 125,838 |
| | 0 |
|
Foreign government bonds | 69,728 |
| | 1,151 |
| | 1,061 |
| | 69,818 |
| | 0 |
|
U.S. public corporate securities | 530,701 |
| | 20,663 |
| | 4,074 |
| | 547,290 |
| | 0 |
|
U.S. private corporate securities | 235,695 |
| | 4,711 |
| | 1,652 |
| | 238,754 |
| | 0 |
|
Foreign public corporate securities | 51,365 |
| | 1,812 |
| | 751 |
| | 52,426 |
| | 0 |
|
Foreign private corporate securities | 153,020 |
| | 2,263 |
| | 3,545 |
| | 151,738 |
| | 0 |
|
Asset-backed securities(1) | 22,342 |
| | 1,082 |
| | 28 |
| | 23,396 |
| | (37 | ) |
Commercial mortgage-backed securities | 146,721 |
| | 2,282 |
| | 1,175 |
| | 147,828 |
| | 0 |
|
Residential mortgage-backed securities(2) | 4,664 |
| | 429 |
| | 2 |
| | 5,091 |
| | (65 | ) |
Total fixed maturities, available-for-sale | $ | 1,350,057 |
| | $ | 40,713 |
| | $ | 12,296 |
| | $ | 1,378,474 |
| | $ | (102 | ) |
| |
(1) | Includes credit-tranched securities collateralized by loan obligations, sub-prime mortgages, education loans and other asset types. |
| |
(2) | Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. |
| |
(3) | Represents the amount of unrealized losses remaining in AOCI, from the impairment measurement date. Amount excludes $0.0 million of net unrealized gains on impaired available-for-sale securities relating to changes in the value of such securities subsequent to the impairment measurement date. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | | | | | | | | | |
| December 31, 2018 |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | OTTI in AOCI(3) |
| (in thousands) |
Fixed maturities, available-for-sale: | | | | | | | | | |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | 15,388 |
| | $ | 940 |
| | $ | 0 |
| | $ | 16,328 |
| | $ | 0 |
|
Obligations of U.S. states and their political subdivisions | 121,031 |
| | 1,830 |
| | 555 |
| | 122,306 |
| | 0 |
|
Foreign government bonds | 68,720 |
| | 96 |
| | 3,522 |
| | 65,294 |
| | 0 |
|
U.S. public corporate securities | 486,872 |
| | 8,798 |
| | 14,945 |
| | 480,725 |
| | 0 |
|
U.S. private corporate securities | 231,953 |
| | 1,935 |
| | 7,522 |
| | 226,366 |
| | 0 |
|
Foreign public corporate securities | 49,684 |
| | 476 |
| | 1,945 |
| | 48,215 |
| | 0 |
|
Foreign private corporate securities | 149,611 |
| | 736 |
| | 5,584 |
| | 144,763 |
| | 0 |
|
Asset-backed securities(1) | 22,352 |
| | 1,040 |
| | 41 |
| | 23,351 |
| | (40 | ) |
Commercial mortgage-backed securities | 147,464 |
| | 915 |
| | 3,173 |
| | 145,206 |
| | 0 |
|
Residential mortgage-backed securities(2) | 4,817 |
| | 460 |
| | 7 |
| | 5,270 |
| | (66 | ) |
Total fixed maturities, available-for-sale | $ | 1,297,892 |
| | $ | 17,226 |
| | $ | 37,294 |
| | $ | 1,277,824 |
| | $ | (106 | ) |
| |
(1) | Includes credit-tranched securities collateralized by loan obligations, sub-prime mortgages, auto loans, education loans and other asset types. |
| |
(2) | Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. |
| |
(3) | Represents the amount of unrealized losses remaining in AOCI, from the impairment measurement date. Amount excludes $0.2 million of net unrealized gains on impaired available-for-sale securities relating to changes in the value of such securities subsequent to the impairment measurement date. |
The following tables set forth the fair value and gross unrealized losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2019 |
| Less Than Twelve Months | | Twelve Months or More | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses |
| (in thousands) |
Fixed maturities, available-for-sale: | | | | | | | | | | | |
Obligations of U.S. states and their political subdivisions | $ | 0 |
| | $ | 0 |
| | $ | 1,985 |
| | $ | 8 |
| | $ | 1,985 |
| | $ | 8 |
|
Foreign government bonds | 4,181 |
| | 28 |
| | 34,371 |
| | 1,033 |
| | 38,552 |
| | 1,061 |
|
U.S. public corporate securities | 21,835 |
| | 533 |
| | 121,350 |
| | 3,541 |
| | 143,185 |
| | 4,074 |
|
U.S. private corporate securities | 18,829 |
| | 373 |
| | 54,532 |
| | 1,279 |
| | 73,361 |
| | 1,652 |
|
Foreign public corporate securities | 0 |
| | 0 |
| | 16,912 |
| | 751 |
| | 16,912 |
| | 751 |
|
Foreign private corporate securities | 45,469 |
| | 1,449 |
| | 26,397 |
| | 2,096 |
| | 71,866 |
| | 3,545 |
|
Asset-backed securities | 4,974 |
| | 28 |
| | 0 |
| | 0 |
| | 4,974 |
| | 28 |
|
Commercial mortgage-backed securities | 0 |
| | 0 |
| | 61,643 |
| | 1,175 |
| | 61,643 |
| | 1,175 |
|
Residential mortgage-backed securities | 186 |
| | 1 |
| | 252 |
| | 1 |
| | 438 |
| | 2 |
|
Total fixed maturities, available-for-sale | $ | 95,474 |
| | $ | 2,412 |
| | $ | 317,442 |
| | $ | 9,884 |
| | $ | 412,916 |
| | $ | 12,296 |
|
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2018 |
| Less Than Twelve Months | | Twelve Months or More | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses |
| (in thousands) |
Fixed maturities, available-for-sale: | | | | | | | | | | | |
Obligations of U.S. states and their political subdivisions | $ | 36,191 |
| | $ | 356 |
| | $ | 7,585 |
| | $ | 199 |
| | $ | 43,776 |
| | $ | 555 |
|
Foreign government bonds | 28,009 |
| | 1,002 |
| | 30,924 |
| | 2,520 |
| | 58,933 |
| | 3,522 |
|
U.S. public corporate securities | 182,958 |
| | 7,696 |
| | 124,396 |
| | 7,249 |
| | 307,354 |
| | 14,945 |
|
U.S. private corporate securities | 57,562 |
| | 4,549 |
| | 106,828 |
| | 2,973 |
| | 164,390 |
| | 7,522 |
|
Foreign public corporate securities | 20,062 |
| | 695 |
| | 16,791 |
| | 1,250 |
| | 36,853 |
| | 1,945 |
|
Foreign private corporate securities | 97,538 |
| | 4,321 |
| | 14,107 |
| | 1,263 |
| | 111,645 |
| | 5,584 |
|
Asset-backed securities | 7,762 |
| | 41 |
| | 0 |
| | 0 |
| | 7,762 |
| | 41 |
|
Commercial mortgage-backed securities | 26,453 |
| | 163 |
| | 61,338 |
| | 3,010 |
| | 87,791 |
| | 3,173 |
|
Residential mortgage-backed securities | 535 |
| | 4 |
| | 243 |
| | 3 |
| | 778 |
| | 7 |
|
Total fixed maturities, available-for-sale | $ | 457,070 |
| | $ | 18,827 |
| | $ | 362,212 |
| | $ | 18,467 |
| | $ | 819,282 |
| | $ | 37,294 |
|
As of March 31, 2019 and December 31, 2018, the gross unrealized losses on fixed maturity securities were composed of $10.4 million and $31.0 million, respectively, related to “1” highest quality or “2” high quality securities based on the National Association of Insurance Commissioners (“NAIC”) or equivalent rating and $1.9 million and $6.3 million, respectively, related to other than high or highest quality securities based on NAIC or equivalent rating. As of March 31, 2019, the $9.9 million of gross unrealized losses of twelve months or more were concentrated in commercial mortgage-backed securities and in the Company’s corporate securities within the finance, consumer non-cyclical and transportation sectors. As of December 31, 2018, the $18.5 million of gross unrealized losses of twelve months or more were concentrated in commercial mortgage-backed securities and in the Company’s corporate securities within the finance, utility and consumer non-cyclical sectors. In accordance with its policy described in Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, the Company concluded that an adjustment to earnings for OTTI for these fixed maturity securities was not warranted at either March 31, 2019 or December 31, 2018. These conclusions were based on a detailed analysis of the underlying credit and cash flows on each security. Gross unrealized losses are primarily attributable to general credit spread widening, increases in interest rates and foreign currency exchange rate movements. As of March 31, 2019, the Company did not intend to sell these securities, and it was not more likely than not that the Company would be required to sell these securities before the anticipated recovery of the remaining amortized cost basis.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:
|
| | | | | | | |
| March 31, 2019 |
| Amortized Cost | | Fair Value |
| (in thousands) |
Fixed maturities, available-for-sale: | | | |
Due in one year or less | $ | 54,953 |
| | $ | 55,011 |
|
Due after one year through five years | 190,539 |
| | 191,982 |
|
Due after five years through ten years | 242,710 |
| | 242,535 |
|
Due after ten years | 688,128 |
| | 712,631 |
|
Asset-backed securities | 22,342 |
| | 23,396 |
|
Commercial mortgage-backed securities | 146,721 |
| | 147,828 |
|
Residential mortgage-backed securities | 4,664 |
| | 5,091 |
|
Total fixed maturities, available-for-sale | $ | 1,350,057 |
| | $ | 1,378,474 |
|
Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Asset-backed, commercial mortgage-backed and residential mortgage-backed securities are shown separately in the table above, as they do not have a single maturity date.
The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on impairments of fixed maturities, for the periods indicated:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
| (in thousands) |
Fixed maturities, available-for-sale: | | | |
Proceeds from sales(1) | $ | 3,256 |
| | $ | 0 |
|
Proceeds from maturities/prepayments | 3,163 |
| | 8,801 |
|
Gross investment gains from sales and maturities | 103 |
| | 2 |
|
Gross investment losses from sales and maturities | (35 | ) | | 0 |
|
OTTI recognized in earnings(2) | (3,163 | ) | | 0 |
|
| |
(1) | Includes $0.9 million and $0.8 million of non-cash related proceeds due to the timing of trade settlements for the three months ended March 31, 2019 and 2018, respectively. |
| |
(2) | Excludes the portion of OTTI amounts remaining in OCI, representing any difference between the fair value of the impaired debt security and the net present value of its projected future cash flows at the time of the impairment. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
The following table sets forth a rollforward of pre-tax amounts remaining in OCI related to fixed maturity securities with credit loss impairments recognized in earnings, for the periods indicated:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
| (in thousands) |
Credit loss impairments: | | | |
Balance, beginning of period | $ | 179 |
| | $ | 561 |
|
New credit loss impairments | 3,021 |
| | 0 |
|
Increases due to the passage of time on previously recorded credit losses | 3 |
| | 11 |
|
Reductions for securities which matured, paid down, prepaid or were sold during the period | (3 | ) | | (12 | ) |
Accretion of credit loss impairments previously recognized due to an increase in cash flows expected to be collected | (58 | ) | | 0 |
|
Balance, end of period | $ | 3,142 |
| | $ | 560 |
|
Equity Securities
The net change in unrealized gains (losses) from equity securities still held at period end, recorded within “Other income,” was $0.2 million and $(0.4) million during the three months ended March 31, 2019 and 2018, respectively.
Commercial Mortgage and Other Loans
The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:
|
| | | | | | | | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| Amount (in thousands) | | % of Total | | Amount (in thousands) | | % of Total |
Commercial mortgage and agricultural property loans by property type: | | | | | | | |
Apartments/Multi-Family | $ | 41,579 |
| | 35.2 | % | | $ | 41,775 |
| | 35.2 | % |
Hospitality | 9,917 |
| | 8.4 |
| | 9,988 |
| | 8.4 |
|
Industrial | 12,257 |
| | 10.4 |
| | 12,264 |
| | 10.3 |
|
Office | 17,023 |
| | 14.4 |
| | 16,930 |
| | 14.3 |
|
Other | 18,983 |
| | 16.1 |
| | 19,024 |
| | 16.0 |
|
Retail | 13,750 |
| | 11.6 |
| | 13,838 |
| | 11.6 |
|
Total commercial mortgage loans | 113,509 |
| | 96.1 |
| | 113,819 |
| | 95.8 |
|
Agricultural property loans | 4,588 |
| | 3.9 |
| | 4,968 |
| | 4.2 |
|
Total commercial mortgage and agricultural property loans by property type | 118,097 |
| | 100.0 | % | | 118,787 |
| | 100.0 | % |
Allowance for credit losses | (139 | ) | | | | (151 | ) | | |
Total commercial mortgage and other loans | $ | 117,958 |
| | | | $ | 118,636 |
| | |
As of March 31, 2019, the commercial mortgage and agricultural property loans were secured by properties geographically dispersed throughout the United States (with the largest concentrations in Illinois (17%), New York (14%) and Texas (10%)) and included loans secured by properties in Europe (8%).
The following table sets forth the activity in the allowance for credit losses for commercial mortgage and other loans, as of the dates indicated:
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | |
| Commercial Mortgage Loans | | Agricultural Property Loans | | Total |
| (in thousands) |
Balance at December 31, 2017 | $ | 179 |
| | $ | 1 |
| | $ | 180 |
|
Addition to (release of) allowance for credit losses | (29 | ) | | 0 |
| | (29 | ) |
Charge-offs, net of recoveries | 0 |
| | 0 |
| | 0 |
|
Balance at December 31, 2018 | 150 |
| | 1 |
| | 151 |
|
Addition to (release of) allowance for credit losses | (12 | ) | | 0 |
| | (12 | ) |
Charge-offs, net of recoveries | 0 |
| | 0 |
| | 0 |
|
Balance at March 31, 2019 | $ | 138 |
| | $ | 1 |
| | $ | 139 |
|
The following tables set forth the allowance for credit losses and the recorded investment in commercial mortgage and other loans, as of the dates indicated:
|
| | | | | | | | | | | |
| March 31, 2019 |
| Commercial Mortgage Loans | | Agricultural Property Loans | | Total |
| (in thousands) |
Allowance for credit losses: | | | | | |
Individually evaluated for impairment | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
Collectively evaluated for impairment | 138 |
| | 1 |
| | 139 |
|
Total ending balance(1) | $ | 138 |
| | $ | 1 |
| | $ | 139 |
|
Recorded investment(2): | | | | | |
Individually evaluated for impairment | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
Collectively evaluated for impairment | 113,509 |
| | 4,588 |
| | 118,097 |
|
Total ending balance(1) | $ | 113,509 |
| | $ | 4,588 |
| | $ | 118,097 |
|
| |
(1) | As of March 31, 2019, there were no loans acquired with deteriorated credit quality. |
| |
(2) | Recorded investment reflects the carrying value gross of related allowance. |
|
| | | | | | | | | | | |
| December 31, 2018 |
| Commercial Mortgage Loans | | Agricultural Property Loans | | Total |
| (in thousands) |
Allowance for credit losses: | | | | | |
Individually evaluated for impairment | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
Collectively evaluated for impairment | 150 |
| | 1 |
| | 151 |
|
Total ending balance(1) | $ | 150 |
| | $ | 1 |
| | $ | 151 |
|
Recorded investment(2): | | | | | |
Individually evaluated for impairment | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
Collectively evaluated for impairment | 113,819 |
| | 4,968 |
| | 118,787 |
|
Total ending balance(1) | $ | 113,819 |
| | $ | 4,968 |
| | $ | 118,787 |
|
| |
(1) | As of December 31, 2018, there were no loans acquired with deteriorated credit quality. |
| |
(2) | Recorded investment reflects the carrying value gross of related allowance. |
The following tables set forth certain key credit quality indicators for commercial mortgage and agricultural property loans based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | | | | | |
| March 31, 2019 |
| Debt Service Coverage Ratio | | |
| ≥ 1.2X | | 1.0X to < 1.2X | | < 1.0X | | Total |
| (in thousands) |
Loan-to-Value Ratio: | | | | | | | |
0%-59.99% | $ | 87,826 |
| | $ | 3,120 |
| | $ | 0 |
| | $ | 90,946 |
|
60%-69.99% | 22,052 |
| | 3,549 |
| | 0 |
| | 25,601 |
|
70%-79.99% | 0 |
| | 1,550 |
| | 0 |
| | 1,550 |
|
80% or greater | 0 |
| | 0 |
| | 0 |
| | 0 |
|
Total commercial mortgage and agricultural property loans | $ | 109,878 |
| | $ | 8,219 |
| | $ | 0 |
| | $ | 118,097 |
|
|
| | | | | | | | | | | | | | | |
| December 31, 2018 |
| Debt Service Coverage Ratio | | |
| ≥ 1.2X | | 1.0X to < 1.2X | | < 1.0X | | Total |
| (in thousands) |
Loan-to-Value Ratio: | | | | | | | |
0%-59.99% | $ | 88,427 |
| | $ | 1,210 |
| | $ | 0 |
| | $ | 89,637 |
|
60%-69.99% | 19,975 |
| | 5,513 |
| | 0 |
| | 25,488 |
|
70%-79.99% | 2,102 |
| | 1,560 |
| | 0 |
| | 3,662 |
|
80% or greater | 0 |
| | 0 |
| | 0 |
| | 0 |
|
Total commercial mortgage and agricultural property loans | $ | 110,504 |
| | $ | 8,283 |
| | $ | 0 |
| | $ | 118,787 |
|
The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2019 |
| Current | | 30-59 Days Past Due | | 60-89 Days Past Due | | 90 Days or More Past Due(1) | | Total Loans | | Non-Accrual Status(2) |
| (in thousands) |
Commercial mortgage loans | $ | 113,509 |
| | $ | 0 |
| | $ | 0 |
| | $ | 0 |
| | $ | 113,509 |
| | $ | 0 |
|
Agricultural property loans | 4,588 |
| | 0 |
| | 0 |
| | 0 |
| | 4,588 |
| | 0 |
|
Total | $ | 118,097 |
| | $ | 0 |
| | $ | 0 |
| | $ | 0 |
| | $ | 118,097 |
| | $ | 0 |
|
| |
(1) | As of March 31, 2019, there were no loans in this category accruing interest. |
| |
(2) | For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. |
|
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2018 |
| Current | | 30-59 Days Past Due | | 60-89 Days Past Due | | 90 Days or More Past Due(1) | | Total Loans | | Non-Accrual Status(2) |
| (in thousands) |
Commercial mortgage loans | $ | 113,819 |
| | $ | 0 |
| | $ | 0 |
| | $ | 0 |
| | $ | 113,819 |
| | $ | 0 |
|
Agricultural property loans | 4,968 |
| | 0 |
| | 0 |
| | 0 |
| | 4,968 |
| | 0 |
|
Total | $ | 118,787 |
| | $ | 0 |
| | $ | 0 |
| | $ | 0 |
| | $ | 118,787 |
| | $ | 0 |
|
| |
(1) | As of December 31, 2018, there were no loans in this category accruing interest. |
| |
(2) | For additional information regarding the Company’s policies for accruing interest on loans, see Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Other Invested Assets
The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| (in thousands) |
Company’s investment in separate accounts | $ | 3,070 |
| | $ | 3,008 |
|
LPs/LLCs: | | | |
Equity method: | | | |
Private equity | 17,656 |
| | 15,081 |
|
Hedge funds | 29,370 |
| | 28,266 |
|
Real estate-related | 1,433 |
| | 1,385 |
|
Subtotal equity method | 48,459 |
| | 44,732 |
|
Fair value: | | | |
Private equity | 929 |
| | 920 |
|
Hedge funds | 106 |
| | 105 |
|
Real estate-related | 1,980 |
| | 1,856 |
|
Subtotal fair value | 3,015 |
| | 2,881 |
|
Total LPs/LLCs | 51,474 |
| | 47,613 |
|
Derivative instruments | 12,914 |
| | 7,792 |
|
Total other invested assets | $ | 67,458 |
| | $ | 58,413 |
|
Net Investment Income
The following table sets forth “Net investment income” by investment type, for the periods indicated:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
| (in thousands) |
Fixed maturities, available-for-sale | $ | 13,558 |
| | $ | 12,639 |
|
Fixed maturities, trading | 77 |
| | 82 |
|
Equity securities, at fair value | 91 |
| | 91 |
|
Commercial mortgage and other loans | 1,177 |
| | 1,239 |
|
Policy loans | 2,734 |
| | 2,657 |
|
Short-term investments and cash equivalents | 280 |
| | 89 |
|
Other invested assets | 1,682 |
| | 673 |
|
Gross investment income | 19,599 |
| | 17,470 |
|
Less: investment expenses | (858 | ) | | (921 | ) |
Net investment income | $ | 18,741 |
| | $ | 16,549 |
|
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Realized Investment Gains (Losses), Net
The following table sets forth “Realized investment gains (losses), net,” by investment type, for the periods indicated:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
| (in thousands) |
Fixed maturities(1) | $ | (3,095 | ) | | $ | 2 |
|
Commercial mortgage and other loans | 12 |
| | (8 | ) |
LPs/LLCs | 11 |
| | 48 |
|
Derivatives | (3,044 | ) | | (3,973 | ) |
Short term investments and cash equivalents | 6 |
| | 0 |
|
Realized investment gains (losses), net | $ | (6,110 | ) | | $ | (3,931 | ) |
| |
(1) | Includes fixed maturity securities classified as available-for-sale and excludes fixed maturity securities classified as trading. |
Net Unrealized Gains (Losses) on Investments within AOCI
The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| (in thousands) |
Fixed maturity securities, available-for-sale—with OTTI | $ | (122 | ) | | $ | 143 |
|
Fixed maturity securities, available-for-sale—all other | 28,539 |
| | (20,211 | ) |
Derivatives designated as cash flow hedges(1) | 1,585 |
| | 1,793 |
|
Affiliated notes | 515 |
| | 509 |
|
Other investments | 34 |
| | 145 |
|
Net unrealized gains (losses) on investments | $ | 30,551 |
| | $ | (17,621 | ) |
| |
(1) | For more information on cash flow hedges, see Note 4. |
Repurchase Agreements and Securities Lending
In the normal course of business, the Company sells securities under agreements to repurchase and enters into securities lending transactions. As of March 31, 2019 and December 31, 2018, the Company had no repurchase agreements.
The following table sets forth the composition of “Cash collateral for loaned securities,” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| Remaining Contractual Maturities of the Agreements | | | | Remaining Contractual Maturities of the Agreements | | |
| Overnight & Continuous | | Up to 30 Days | | Total | | Overnight & Continuous | | Up to 30 Days | | Total |
| (in thousands) |
Foreign government bonds | 728 |
| | 0 |
| | 728 |
| | 0 |
| | 0 |
| | 0 |
|
U.S. public corporate securities | 0 |
| | 0 |
| | 0 |
| | 437 |
| | 0 |
| | 437 |
|
Foreign public corporate securities | 2,359 |
| | 0 |
| | 2,359 |
| | 2,265 |
| | 0 |
| | 2,265 |
|
Total cash collateral for loaned securities(1) | $ | 3,087 |
| | $ | 0 |
| | $ | 3,087 |
| | $ | 2,702 |
| | $ | 0 |
| | $ | 2,702 |
|
| |
(1) | The Company did not have any agreements with remaining contractual maturities of thirty days or greater, as of the dates indicated. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
4. DERIVATIVE INSTRUMENTS
Types of Derivative Instruments and Derivative Strategies
The Company utilizes various derivative instruments and strategies to manage its risk. Commonly used derivative instruments include, but are not necessarily limited to:
•Interest rate contracts: futures, swaps, options, swaptions, caps and floors
•Equity contracts: futures, options and total return swaps
•Foreign exchange contracts: futures, options, forwards and swaps
•Credit contracts: single and index reference credit default swaps
Other types of financial contracts that the company accounts for as derivatives include:
•Embedded derivatives
For detailed information on these contracts and the related strategies, see Note 4 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.
Primary Risks Managed by Derivatives
The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks, excluding embedded derivatives and associated reinsurance recoverables. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the gross fair value of derivative contracts prior to taking into account the netting effects of master netting agreements, cash collateral, and NPR.
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | March 31, 2019 | | December 31, 2018 |
| | | | Gross Fair Value | | | | Gross Fair Value |
Primary Underlying Risk/Instrument Type | | Notional | Assets | | Liabilities | | Notional | Assets | | Liabilities |
| | (in thousands) |
Derivatives Designated as Hedge Accounting Instruments: | | | | | | | | | | | | |
Currency/Interest Rate | | | | | | | | | | | | |
Foreign Currency Swaps | | $ | 123,178 |
| | $ | 3,612 |
| | $ | (2,617 | ) | | $ | 119,611 |
| | $ | 3,787 |
| | $ | (2,271 | ) |
Total Derivatives Designated as Hedge Accounting Instruments: | | $ | 123,178 |
| | $ | 3,612 |
| | $ | (2,617 | ) | | $ | 119,611 |
| | $ | 3,787 |
| | $ | (2,271 | ) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | | | | | | | | | | | | |
Interest Rate | | | | | | | | | | | | |
Interest Rate Swaps | | $ | 59,075 |
| | $ | 2,408 |
| | $ | 0 |
| | $ | 59,075 |
| | $ | 2,360 |
| | $ | 0 |
|
Credit | | | | | | | | | | | | |
Credit Default Swaps | | 0 |
| | 0 |
| | 0 |
| | 756 |
| | 0 |
| | (9 | ) |
Currency/Interest Rate | | | | | | | | | | | | |
Foreign Currency Swaps | | 16,815 |
| | 2,260 |
| | 0 |
| | 16,815 |
| | 2,364 |
| | (111 | ) |
Foreign Currency | | | | | | | | | | | | |
Foreign Currency Forwards | | 1,214 |
| | 19 |
| | (1 | ) | | 1,460 |
| | 21 |
| | 0 |
|
Equity | | | | | | | | | | | | |
Equity Options | | 301,799 |
| | 10,039 |
| | (2,683 | ) | | 281,400 |
| | 2,616 |
| | (749 | ) |
Total Derivatives Not Qualifying as Hedge Accounting Instruments: | | $ | 378,903 |
| | $ | 14,726 |
| | $ | (2,684 | ) | | $ | 359,506 |
| | $ | 7,361 |
| | $ | (869 | ) |
Total Derivatives(1)(2) | | $ | 502,081 |
| | $ | 18,338 |
| | $ | (5,301 | ) | | $ | 479,117 |
| | $ | 11,148 |
| | $ | (3,140 | ) |
| |
(1) | Excludes embedded derivatives and associated reinsurance recoverables which contain multiple underlying risks. |
| |
(2) | Recorded in "Other invested assets" and "Other liabilities" on the Unaudited Interim Consolidated Statements of Financial Position. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
The fair value of the embedded derivatives, included in "Future policy benefits," was a net liability of $571 million and $489 million as of March 31, 2019 and December 31, 2018, respectively. The fair value of the related reinsurance recoverables, included in "Reinsurance recoverables," was a net asset of $571 million and $489 million as of March 31, 2019 and December 31, 2018, respectively. See Note 6 for additional information on these reinsurance agreements.
The fair value of the embedded derivatives, included in "Policyholders' account balances," was a net liability of $8 million and $2 million as of March 31, 2019 and December 31, 2018, respectively. There were no related reinsurance recoverables at each respective period.
Offsetting Assets and Liabilities
The following table presents recognized derivative instruments (excluding embedded derivatives and associated reinsurance recoverables), and repurchase and reverse repurchase agreements that are offset in the Unaudited Interim Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Unaudited Interim Statements of Financial Position.
|
| | | | | | | | | | | | | | | | | | | |
| March 31, 2019 |
| Gross Amounts of Recognized Financial Instruments | | Gross Amounts Offset in the Statements of Financial Position | | Net Amounts Presented in the Statements of Financial Position | | Financial Instruments/ Collateral(1) | | Net Amount |
| (in thousands) |
Offsetting of Financial Assets: | | | | | | | | | |
Derivatives(1) | $ | 18,338 |
| | $ | (5,424 | ) | | $ | 12,914 |
| | $ | (12,809 | ) | | $ | 105 |
|
Securities purchased under agreements to resell | 0 |
| | 0 |
| | 0 |
| | 0 |
| | 0 |
|
Total Assets | $ | 18,338 |
| | $ | (5,424 | ) | | $ | 12,914 |
| | $ | (12,809 | ) | | $ | 105 |
|
Offsetting of Financial Liabilities: | | | | | | | | | |
Derivatives(1) | $ | 5,301 |
| | $ | (5,301 | ) | | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
Securities sold under agreements to repurchase | 0 |
| | 0 |
| | 0 |
| | 0 |
| | 0 |
|
Total Liabilities | $ | 5,301 |
| | $ | (5,301 | ) | | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
|
| | | | | | | | | | | | | | | | | | | |
| December 31, 2018 |
| Gross Amounts of Recognized Financial Instruments | | Gross Amounts Offset in the Statements of Financial Position | | Net Amounts Presented in the Statements of Financial Position | | Financial Instruments/ Collateral(1) | | Net Amount |
| (in thousands) |
Offsetting of Financial Assets: | | | | | | | | | |
Derivatives(1) | $ | 11,148 |
| | $ | (3,355 | ) | | $ | 7,793 |
| | $ | (7,307 | ) | | $ | 486 |
|
Securities purchased under agreements to resell | 10,000 |
| | 0 |
| | 10,000 |
| | (10,000 | ) | | 0 |
|
Total Assets | $ | 21,148 |
| | $ | (3,355 | ) | | $ | 17,793 |
| | $ | (17,307 | ) | | $ | 486 |
|
Offsetting of Financial Liabilities: | | | | | | | | | |
Derivatives(1) | $ | 3,140 |
| | $ | (3,140 | ) | | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
Securities sold under agreements to repurchase | 0 |
| | 0 |
| | 0 |
| | 0 |
| | 0 |
|
Total Liabilities | $ | 3,140 |
| | $ | (3,140 | ) | | $ | 0 |
| | $ | 0 |
| | $ | 0 |
|
| |
(1) | Amounts exclude the excess of collateral received/pledged from/to the counterparty. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
For information regarding the rights of offset associated with the derivative assets and liabilities in the table above see “Credit Risk” below and Note 9. For securities purchased under agreements to resell and securities sold under agreements to repurchase, the Company monitors the value of the securities and maintains collateral, as appropriate, to protect against credit exposure. Where the Company has entered into repurchase and resale agreements with the same counterparty, in the event of default, the Company would generally be permitted to exercise rights of offset. For additional information on the Company’s accounting policy for securities repurchase and resale agreements, see Note 2 to the Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.
Cash Flow Hedges
The primary derivative instruments used by the Company in its cash flow hedge accounting relationships are currency swaps. These instruments are only designated for hedge accounting in instances where the appropriate criteria are met. The Company does not use futures, options, credit, equity or embedded derivatives in any of its cash flow hedge accounting relationships.
The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, excluding the offset of the hedged item in an effective hedge relationship.
|
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2019 |
| Realized Investment Gains (Losses) | | Net Investment Income | | Other Income | | AOCI (1) |
| (in thousands) |
Derivatives Designated as Hedge Accounting Instruments: | | | | | | | |
Cash flow hedges | | | | | | | |
Currency/Interest Rate | $ | (10 | ) | | $ | 398 |
| | $ | (209 | ) | | $ | (217 | ) |
Total cash flow hedges | (10 | ) | | 398 |
| | (209 | ) | | (217 | ) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | | | | | | | |
Interest Rate | 509 |
| | 0 |
| | 0 |
| | 0 |
|
Currency | 6 |
| | 0 |
| | 0 |
| | 0 |
|
Currency/Interest Rate | 110 |
| | 0 |
| | (2 | ) | | 0 |
|
Credit | (1 | ) | | 0 |
| | 0 |
| | 0 |
|
Equity | 4,140 |
| | 0 |
| | 0 |
| | 0 |
|
Embedded Derivatives | (7,798 | ) | | 0 |
| | 0 |
| | 0 |
|
Total Derivatives Not Qualifying as Hedge Accounting Instruments: | (3,034 | ) | | 0 |
| | (2 | ) | | 0 |
|
Total | $ | (3,044 | ) | | $ | 398 |
| | $ | (211 | ) | | $ | (217 | ) |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2018 (2) |
| Realized Investment Gains (Losses) | | Net Investment Income | | Other Income | | AOCI(1) |
| (in thousands) |
Derivatives Designated as Hedge Accounting Instruments: | | | | | | | |
Cash flow hedges | | | | | | | |
Currency/Interest Rate | $ | (557 | ) | | $ | 313 |
| | $ | (410 | ) | | $ | (4,437 | ) |
Total cash flow hedges | (557 | ) | | 313 |
| | (410 | ) | | (4,437 | ) |
Derivatives Not Qualifying as Hedge Accounting Instruments: | | | | | | | |
Interest Rate | (874 | ) | | 0 |
| | 0 |
| | 0 |
|
Currency | (54 | ) | | 0 |
| | 0 |
| | 0 |
|
Currency/Interest Rate | (364 | ) | | 0 |
| | (7 | ) | | 0 |
|
Credit | (1 | ) | | 0 |
| | 0 |
| | 0 |
|
Equity | (573 | ) | | 0 |
| | 0 |
| | 0 |
|
Embedded Derivatives | (1,550 | ) | | 0 |
| | 0 |
| | 0 |
|
Total Derivatives Not Qualifying as Hedge Accounting Instruments: | (3,416 | ) | | 0 |
| | (7 | ) | | 0 |
|
Total | $ | (3,973 | ) | | $ | 313 |
| | $ | (417 | ) | | $ | (4,437 | ) |
| |
(2) | Prior period amounts have been updated to conform to current period presentation. |
Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
|
| | | |
| (in thousands) |
Balance, December 31, 2018 | $ | 1,793 |
|
Cumulative-effect adjustment from the adoption of ASU 2017-12(1) | 9 |
|
Amount recorded in AOCI | |
Currency/Interest Rate | (38 | ) |
Total amount recorded in AOCI | (38 | ) |
Amount reclassified from AOCI to income | |
Currency/Interest Rate | (179 | ) |
Total amount reclassified from AOCI to income | (179 | ) |
Balance, March 31, 2019 | $ | 1,585 |
|
| |
(1) | See Note 2 for details. |
The changes in fair value of cash flow hedges are deferred in AOCI and are included in “Net unrealized investment gains (losses)” in the Unaudited Interim Statements of Operations and Comprehensive Income (Loss); these amounts are then reclassified to earnings when the hedged item affects earnings. Using March 31, 2019 values, it is estimated that a pre-tax gain of $1.6 million is expected to be reclassified from AOCI to earnings during the subsequent twelve months ending March 31, 2020, offset by amounts pertaining to the hedged items.
The exposures the Company is hedging with these qualifying cash flow hedges include the variability of the payment or receipt of interest or foreign currency amounts on existing financial instruments.
There were no material amounts reclassified from AOCI into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Credit Derivatives
The Company has no exposure from credit derivative positions where it has written credit protection as of March 31, 2019 and December 31, 2018.
The Company has purchased credit protection using credit derivatives in order to hedge specific credit exposures in the Company’s investment portfolio. The Company has outstanding notional amounts of $0.0 million and $1 million reported as of March 31, 2019 and December 31, 2018, respectively with a fair value of $0.0 million for both periods.
Credit Risk
The Company is exposed to credit-related losses in the event of non-performance by counterparty to financial derivative transactions with a positive fair value. The Company manages credit risk by entering into derivative transactions with its affiliate, Prudential Global Funding LLC (“PGF”), related to its over-the-counter ("OTC") derivatives. PGF, in turn, manages its credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreement, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single-party credit exposures which are subject to periodic management review.
Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position.
5. FAIR VALUE OF ASSETS AND LIABILITIES
Fair Value Measurement – Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative fair value guidance establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level 1 - Fair value is based on unadjusted quoted prices in active markets that are accessible to the Company for identical assets or liabilities.
Level 2 - Fair value is based on significant inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability through corroboration with observable market data. Level 2 inputs include quoted market prices in active markets for similar assets and liabilities, quoted market prices in markets that are not active for identical or similar assets or liabilities, and other market observable inputs.
Level 3 - Fair value is based on at least one significant unobservable input for the asset or liability. The assets and liabilities in this category may require significant judgment or estimation in determining the fair value.
For a discussion of the Company's valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 5 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Assets and Liabilities by Hierarchy Level – The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated.
|
| | | | | | | | | | | | | | | | | | | |
| As of March 31, 2019 |
| Level 1 | | Level 2 | | Level 3 | | Netting(1) | | Total |
| (in thousands) |
Fixed maturities, available-for-sale: | | | | | | | | | |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | 0 |
| | $ | 16,295 |
| | $ | 0 |
| | $ | 0 |
| | $ | 16,295 |
|
Obligations of U.S. states and their political subdivisions | 0 |
| | 125,838 |
| | 0 |
| | 0 |
| | 125,838 |
|
Foreign government bonds | 0 |
| | 69,818 |
| | 0 |
| | 0 |
| | 69,818 |
|
U.S. corporate public securities | 0 |
| | 547,290 |
| | 0 |
| | 0 |
| | 547,290 |
|
U.S. corporate private securities | 0 |
| | 237,188 |
| | 1,566 |
| | 0 |
| | 238,754 |
|
Foreign corporate public securities | 0 |
| | 52,426 |
| | 0 |
| | 0 |
| | 52,426 |
|
Foreign corporate private securities | 0 |
| | 150,960 |
| | 778 |
| | 0 |
| | 151,738 |
|
Asset-backed securities(2) | 0 |
| | 23,396 |
| | 0 |
| | 0 |
| | 23,396 |
|
Commercial mortgage-backed securities | 0 |
| | 122,504 |
| | 25,324 |
| | 0 |
| | 147,828 |
|
Residential mortgage-backed securities | 0 |
| | 5,091 |
| | 0 |
| | 0 |
| | 5,091 |
|
Subtotal | 0 |
| | 1,350,806 |
| | 27,668 |
| | 0 |
| | 1,378,474 |
|
Fixed maturities, trading | 0 |
| | 6,182 |
| | 0 |
| | 0 |
| | 6,182 |
|
Equity securities | 0 |
| | 3,551 |
| | 6,576 |
| | 0 |
| | 10,127 |
|
Cash equivalents | 0 |
| | 47,131 |
| | 0 |
| | 0 |
| | 47,131 |
|
Other invested assets(3) | 0 |
| | 18,338 |
| | 0 |
| | (5,424 | ) | | 12,914 |
|
Reinsurance recoverables | 0 |
| | 0 |
| | 571,117 |
| | 0 |
| | 571,117 |
|
Receivables from parent and affiliates | 0 |
| | 2,761 |
| | 0 |
| | 0 |
| | 2,761 |
|
Subtotal excluding separate account assets | 0 |
| | 1,428,769 |
| | 605,361 |
| | (5,424 | ) | | 2,028,706 |
|
Separate account assets(4)(5) | 0 |
| | 12,775,073 |
| | 0 |
| | 0 |
| | 12,775,073 |
|
Total assets | $ | 0 |
| | $ | 14,203,842 |
| | $ | 605,361 |
| | $ | (5,424 | ) | | $ | 14,803,779 |
|
Future policy benefits(6) | $ | 0 |
| | $ | 0 |
| | $ | 571,117 |
| | $ | 0 |
| | $ | 571,117 |
|
Policyholders' account balances | 0 |
| | 0 |
| | 7,529 |
| | 0 |
| | 7,529 |
|
Payables to parent and affiliates | 0 |
| | 5,301 |
| | 0 |
| | (5,301 | ) | | 0 |
|
Total liabilities | $ | 0 |
| | $ | 5,301 |
| | $ | 578,646 |
| | $ | (5,301 | ) | | $ | 578,646 |
|
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | | | | | | | | | |
| As of December 31, 2018 |
| Level 1 | | Level 2 | | Level 3 | | Netting(1) | | Total |
| (in thousands) |
Fixed maturities, available-for-sale: | | | | | | | | | |
U.S. Treasury securities and obligations of U.S. government authorities and agencies | $ | 0 |
| | $ | 16,328 |
| | $ | 0 |
| | $ | 0 |
| | $ | 16,328 |
|
Obligations of U.S. states and their political subdivisions | 0 |
| | 122,306 |
| | 0 |
| | 0 |
| | 122,306 |
|
Foreign government bonds | 0 |
| | 65,294 |
| | 0 |
| | 0 |
| | 65,294 |
|
U.S. corporate public securities | 0 |
| | 480,725 |
| | 0 |
| | 0 |
| | 480,725 |
|
U.S. corporate private securities | 0 |
| | 224,278 |
| | 2,088 |
| | 0 |
| | 226,366 |
|
Foreign corporate public securities | 0 |
| | 48,215 |
| | 0 |
| | 0 |
| | 48,215 |
|
Foreign corporate private securities | 0 |
| | 143,969 |
| | 794 |
| | 0 |
| | 144,763 |
|
Asset-backed securities(2) | 0 |
| | 23,351 |
| | 0 |
| | 0 |
| | 23,351 |
|
Commercial mortgage-backed securities | 0 |
| | 145,206 |
| | 0 |
| | 0 |
| | 145,206 |
|
Residential mortgage-backed securities | 0 |
| | 5,270 |
| | 0 |
| | 0 |
| | 5,270 |
|
Subtotal | 0 |
| | 1,274,942 |
| | 2,882 |
| | 0 |
| | 1,277,824 |
|
Fixed maturities, trading | 0 |
| | 5,770 |
| | 0 |
| | 0 |
| | 5,770 |
|
Equity securities | 0 |
| | 3,248 |
| | 6,622 |
| | 0 |
| | 9,870 |
|
Cash equivalents | 19,972 |
| | 39,946 |
| | 0 |
| | 0 |
| | 59,918 |
|
Other invested assets(3) | 0 |
| | 11,148 |
| | 0 |
| | (3,355 | ) | | 7,793 |
|
Reinsurance recoverables | 0 |
| | 0 |
| | 488,825 |
| | 0 |
| | 488,825 |
|
Receivables from parent and affiliates | 0 |
| | 8,824 |
| | 0 |
| | 0 |
| | 8,824 |
|
Subtotal excluding separate account assets | 19,972 |
| | 1,343,878 |
| | 498,329 |
| | (3,355 | ) | | 1,858,824 |
|
Separate account assets(4)(5) | 0 |
| | 11,648,322 |
| | 0 |
| | 0 |
| | 11,648,322 |
|
Total assets | $ | 19,972 |
| | $ | 12,992,200 |
| | $ | 498,329 |
| | $ | (3,355 | ) | | $ | 13,507,146 |
|
Future policy benefits(6) | $ | 0 |
| | $ | 0 |
| | $ | 488,825 |
| | $ | 0 |
| | $ | 488,825 |
|
Policyholders' account balances | 0 |
| | 0 |
| | 1,949 |
| | 0 |
| | 1,949 |
|
Payables to parent and affiliates | 0 |
| | 3,140 |
| | 0 |
| | (3,140 | ) | | 0 |
|
Total liabilities | $ | 0 |
| | $ | 3,140 |
| | $ | 490,774 |
| | $ | (3,140 | ) | | $ | 490,774 |
|
| |
(1) | “Netting” amounts represent cash collateral of $0.1 million and $0.2 million as of March 31, 2019 and December 31, 2018, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting arrangements. |
| |
(2) | Includes credit tranched securities collateralized by syndicated bank loans, sub-prime mortgages, auto loans, credit cards, education loans and other asset types. |
| |
(3) | Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value ("NAV") per share (or its equivalent) as a practical expedient. At March 31, 2019 and December 31, 2018, the fair values of such investments were $3.0 million and $2.9 million, respectively. |
| |
(4) | Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Unaudited Interim Statements of Financial Position. |
| |
(5) | Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and a corporate owned life insurance fund, for which fair value is measured at NAV per share (or its equivalent). At March 31, 2019 and December 31, 2018, the fair value of such investments was $1,856 million and $1,734 million, respectively. |
| |
(6) | As of March 31, 2019, the net embedded derivative liability position of $571 million includes $59 million of embedded derivatives in an asset position and $630 million of embedded derivatives in a liability position. As of December 31, 2018, the net embedded derivative liability position of $489 million includes $60 million of embedded derivatives in an asset position and $549 million of embedded derivatives in a liability position. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Quantitative Information Regarding Internally Priced Level 3 Assets and Liabilities – The tables below present quantitative information on significant internally-priced Level 3 assets and liabilities.
|
| | | | | | | | | | | | | | | | | | | | | |
| As of March 31, 2019 |
| Fair Value | | Valuation Techniques | | Unobservable Inputs | | Minimum | | Maximum | | Weighted Average | | Impact of Increase in Input on Fair Value(1) |
| (in thousands) | | | | | | | | | | | | | |
Assets: | | | | | | | | | | | | | | | | |
Corporate securities(2) | $ | 2,344 |
| | Discounted cash flow | | Discount rate | | 18.50 | % |
| | 20.00 | % |
| | 19.41 | % |
| | Decrease |
Reinsurance recoverables | $ | 571,117 |
| | Fair values are determined using the same unobservable inputs as future policy benefits.
|
Liabilities: | | | | | | | | | | | | | | | | |
Future policy benefits(3) | $ | 571,117 |
| | Discounted cash flow | | Lapse rate(4) | | 1 | % | | | 13 | % | | | | | | Decrease |
| | | | | Spread over LIBOR(5) | | 0.12 | % | | | 1.35 | % | | | | | | Decrease |
| | | | | Utilization rate(6) | | 50 | % | | | 97 | % | | | | | | Increase |
| | | | | Withdrawal rate | | | | | | See table footnote (7) below |
| | | | | Mortality rate (8) | | 0 | % | | | 15 | % | | | | | | Decrease |
| | | | | Equity volatility curve | | 15 | % | | | 22 | % | | | | | | Increase |
|
| | | | | | | | | | | | | | | | | | | | | |
| As of December 31, 2018 |
| Fair Value | | Valuation Techniques | | Unobservable Inputs | | Minimum | | Maximum | | Weighted Average | | Impact of Increase in Input on Fair Value(1) |
| (in thousands) | | | | | | | | | | | | | |
Assets: | | | | | | | | | | | | | | | | |
Corporate securities(2) | $ | 2,882 |
| | Discounted cash flow | | Discount rate | | 7.00 | % | | | 16.33 | % | | | 9.93 | % | | | Decrease |
Reinsurance recoverables | $ | 488,825 |
| | Fair values are determined using the same unobservable inputs as future policy benefits.
|
Liabilities: | | | | | | | | | | | | | | | | |
Future policy benefits(3) | $ | 488,825 |
| | Discounted cash flow | | Lapse rate(4) | | 1 | % | | | 13 | % | | | | | | Decrease |
| | | | | Spread over LIBOR(5) | | 0.36 | % | | | 1.60 | % | | | | | | Decrease |
| | | | | Utilization rate(6) | | 50 | % | | | 97 | % | | | | | | Increase |
| | | | | Withdrawal rate | | See table footnote(7) below. |
| | | | | Mortality rate(8) | | 0 | % | | | 15 | % | | | | | | Decrease |
| | | | | Equity volatility curve | | 18 | % | | | 22 | % | | | | | | Increase |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
| |
(1) | Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. |
| |
(2) | Includes assets classified as fixed maturities available-for-sale. |
| |
(3) | Future policy benefits primarily represent general account liabilities for the living benefit features of the Company’s variable annuity contracts which are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. |
| |
(4) | Lapse rates are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. |
| |
(5) | The spread over the London Inter-Bank Offered Rate ("LIBOR") swap curve represents the premium added to the proxy for the risk-free rate (LIBOR) to reflect our estimates of rates that a market participant would use to value the living benefit contracts in both the accumulation and payout phases. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because both funding agreements and living benefit contracts are insurance liabilities and are therefore senior to debt. |
| |
(6) | The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. |
| |
(7) | The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of March 31, 2019 and December 31, 2018, the minimum withdrawal rate assumption is 78% and the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. |
| |
(8) | Range reflects the mortality rate for the vast majority of business with living benefits, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain benefits do not have an age restriction. This results in contractholders for certain benefits with mortality rates approaching 0%. Based on historical experience, the Company applies a set of age and duration specific mortality rate adjustments compared to standard industry tables. A mortality improvement assumption is also incorporated into the overall mortality table. |
Interrelationships Between Unobservable Inputs – In addition to the sensitivities of fair value measurements to changes in each unobservable input in isolation, as reflected in the table above, interrelationships between these inputs may also exist, such that a change in one unobservable input may give rise to a change in another, or multiple, inputs. For the discussion of the relationships between unobservable inputs as well as market factors that may affect the range of inputs used in the valuation of Level 3 assets and liabilities, see Note 5 to the Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Changes in Level 3 Assets and Liabilities – The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods. When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. All transfers are generally reported at the value as of the beginning of the quarter in which transfers occur for any such assets still held at the end of the quarter.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2019 | |
| Fair Value, beginning of period | Total realized and unrealized gains (losses)(1) | Purchases | Sales | Issuances | Settlements | Other | Transfers into Level 3 | Transfers out of Level 3 | Fair Value, end of period | Unrealized gains (losses) for assets still held(2) |
| (in thousands) | |
Fixed maturities, available-for-sale: | | | | | | | | | | | |
Corporate securities(3) | $ | 2,882 |
| $ | (786 | ) | $ | 248 |
| $ | 0 |
| $ | 0 |
| $ | 0 |
| $ | 0 |
| $ | 0 |
| $ | 0 |
| $ | 2,344 |
| $ | (3,163 | ) |
Structured securities(4) | 0 |
| 432 |
| 0 |
| 0 |
| 0 |
| (68 | ) | 0 |
| 24,960 |
| 0 |
| 25,324 |
| 0 |
|
Other assets: | | | | | | | | | | | |
Equity securities | 6,622 |
| (46 | ) | 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 6,576 |
| (46 | ) |
Reinsurance recoverables | 488,825 |
| 59,790 |
| 22,502 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 571,117 |
| 63,207 |
|
Receivables from parent and affiliates | 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
|
Liabilities: | | | | | | | | | | | |
Future policy benefits | (488,825 | ) | (59,790 | ) | 0 |
| 0 |
| (22,502 | ) | 0 |
| 0 |
| 0 |
| 0 |
| (571,117 | ) | (63,207 | ) |
Policyholders' account balances | (1,949 | ) | (4,677 | ) | 0 |
| 0 |
| 0 |
| (903 | ) | 0 |
| 0 |
| 0 |
| (7,529 | ) | (4,677 | ) |
|
| | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2019 |
| Total realized and unrealized gains (losses) | | Unrealized gains (losses) for assets still held(2) |
| Realized investment gains (losses), net(1) | Other income (loss) | Included in other comprehensive income (loss) | Net investment income | | Realized investment gains (losses), net | Other income (loss) |
| (in thousands) |
Fixed maturities, available-for-sale | $ | (3,163 | ) | $ | 0 |
| $ | 2,800 |
| $ | 9 |
| | $ | (3,163 | ) | $ | 0 |
|
Other assets: | | | | | | | |
Equity securities | 0 |
| (46 | ) | 0 |
| 0 |
| | 0 |
| (46 | ) |
Reinsurance recoverables | 59,790 |
| 0 |
| 0 |
| 0 |
| | 63,207 |
| 0 |
|
Receivables from parent and affiliates | 0 |
| 0 |
| 0 |
| 0 |
| | 0 |
| 0 |
|
Liabilities: | | | | | | | |
Future policy benefits | (59,790 | ) | 0 |
| 0 |
| 0 |
| | (63,207 | ) | 0 |
|
Policyholders' account balances | (4,677 | ) | 0 |
| 0 |
| 0 |
| | (4,677 | ) | 0 |
|
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2018(5) | |
| Fair Value, beginning of period | Total realized and unrealized gains (losses)(1) | Purchases | Sales | Issuances | Settlements | Other | Transfers into Level 3 | Transfers out of Level 3 | Fair Value, end of period | Unrealized gains (losses) for assets still held(2) |
| (in thousands) | |
Fixed maturities, available-for-sale: | | | | | | | | | | | |
Corporate securities(3) | $ | 14,516 |
| $ | 192 |
| $ | 60 |
| $ | 0 |
| $ | 0 |
| $ | (147 | ) | $ | 0 |
| $ | 0 |
| $ | 0 |
| $ | 14,621 |
| $ | 0 |
|
Structured securities(4) | 11,575 |
| 5 |
| 190 |
| 0 |
| 0 |
| (5 | ) | 0 |
| 196 |
| (3,506 | ) | 8,455 |
| 0 |
|
Other assets: | | | | | | | | | | | |
Equity securities | 7,428 |
| (245 | ) | 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 7,183 |
| (245 | ) |
Reinsurance recoverables | 472,157 |
| (135,121 | ) | 21,355 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 358,391 |
| (131,213 | ) |
Receivables from parent and affiliates | 0 |
| (18 | ) | 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 6,047 |
| 0 |
| 6,029 |
| 0 |
|
Liabilities: | | | | | | | | | | | |
Future policy benefits | (472,157 | ) | 135,121 |
| 0 |
| 0 |
| (21,355 | ) | 0 |
| 0 |
| 0 |
| 0 |
| (358,391 | ) | 131,213 |
|
Policyholders' account balances | (5,463 | ) | 617 |
| 0 |
| 0 |
| 0 |
| (64 | ) | 0 |
| 0 |
| 0 |
| (4,910 | ) | 617 |
|
|
| | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2018(5) |
| Total realized and unrealized gains (losses) | | Unrealized gains (losses) for assets still held(2) |
| Realized investment gains (losses), net(1) | Other income (loss) | Included in other comprehensive income (loss) | Net investment income | | Realized investment gains (losses), net | Other income (loss) |
| (in thousands) |
Fixed maturities, available-for-sale | $ | 0 |
| $ | 0 |
| $ | 165 |
| $ | 32 |
| | $ | 0 |
| $ | 0 |
|
Other assets: | | | | | | | |
Equity securities | 0 |
| (245 | ) | 0 |
| 0 |
| | 0 |
| (245 | ) |
Reinsurance recoverables | (135,121 | ) | 0 |
| 0 |
| 0 |
| | (131,213 | ) | 0 |
|
Receivables from parent and affiliates | 0 |
| 0 |
| (18 | ) | 0 |
| | 0 |
| 0 |
|
Liabilities: | | | | | | | |
Future policy benefits | 135,121 |
| 0 |
| 0 |
| 0 |
| | 131,213 |
| 0 |
|
Policyholders' account balances | 617 |
| 0 |
| 0 |
| 0 |
| | 617 |
| 0 |
|
| |
(1) | Realized investment gains (losses) on future policy benefits and reinsurance recoverables primarily represent the change in the fair value of the Company's living benefit guarantees on certain of its variable annuity contracts. |
| |
(2) | Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. |
| |
(3) | Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. |
| |
(4) | Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities. |
| |
(5) | Prior period amounts have been updated to conform to current period presentation. |
Fair Value of Financial Instruments
The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Unaudited Interim Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
|
| | | | | | | | | | | | | | | | | | | |
| March 31, 2019 |
| Fair Value | | Carrying Amount(1) |
| Level 1 | | Level 2 | | Level 3 | | Total | | Total |
| (in thousands) |
Assets: | | | | | | | | | |
Commercial mortgage and other loans | $ | 0 |
| | $ | 0 |
| | $ | 120,867 |
| | $ | 120,867 |
| | $ | 117,958 |
|
Policy loans | 0 |
| | 0 |
| | 207,649 |
| | 207,649 |
| | 207,649 |
|
Cash and cash equivalents | 824 |
| | 0 |
| | 0 |
| | 824 |
| | 824 |
|
Accrued investment income | 0 |
| | 18,133 |
| | 0 |
| | 18,133 |
| | 18,133 |
|
Receivables from parent and affiliates | 0 |
| | 30,445 |
| | 0 |
| | 30,445 |
| | 30,445 |
|
Other assets | 0 |
| | 5,479 |
| | 0 |
| | 5,479 |
| | 5,479 |
|
Total assets | $ | 824 |
| | $ | 54,057 |
| | $ | 328,516 |
| | $ | 383,397 |
| | $ | 380,488 |
|
Liabilities: | | | | | | | | | |
Policyholders’ account balances - investment contracts | $ | 0 |
| | $ | 187,665 |
| | $ | 40,605 |
| | $ | 228,270 |
| | $ | 228,815 |
|
Cash collateral for loaned securities | 0 |
| | 3,087 |
| | 0 |
| | 3,087 |
| | 3,087 |
|
Payables to parent and affiliates | 0 |
| | 23,622 |
| | 0 |
| | 23,622 |
| | 23,622 |
|
Other liabilities | 0 |
| | 40,393 |
| | 0 |
| | 40,393 |
| | 40,393 |
|
Total liabilities | $ | 0 |
| | $ | 254,767 |
| | $ | 40,605 |
| | $ | 295,372 |
| | $ | 295,917 |
|
|
| | | | | | | | | | | | | | | | | | | |
| December 31, 2018 |
| Fair Value | | Carrying Amount(1) |
| Level 1 | | Level 2 | | Level 3 | | Total | | Total |
| (in thousands) |
Assets: | | | | | | | | | |
Commercial mortgage and other loans | $ | 0 |
| | $ | 0 |
| | $ | 119,659 |
| | $ | 119,659 |
| | $ | 118,636 |
|
Policy loans | 0 |
| | 0 |
| | 206,448 |
| | 206,448 |
| | 206,448 |
|
Cash and cash equivalents | 523 |
| | 10,000 |
| | 0 |
| | 10,523 |
| | 10,523 |
|
Accrued investment income | 0 |
| | 17,764 |
| | 0 |
| | 17,764 |
| | 17,764 |
|
Receivables from parent and affiliates | 0 |
| | 31,564 |
| | 0 |
| | 31,564 |
| | 31,564 |
|
Other assets | 0 |
| | 4,193 |
| | 0 |
| | 4,193 |
| | 4,193 |
|
Total assets | $ | 523 |
| | $ | 63,521 |
| | $ | 326,107 |
| | $ | 390,151 |
| | $ | 389,128 |
|
Liabilities: | | | | | | | | | |
Policyholders’ account balances - investment contracts | $ | 0 |
| | $ | 179,239 |
| | $ | 40,349 |
| | $ | 219,588 |
| | $ | 220,553 |
|
Cash collateral for loaned securities | 0 |
| | 2,702 |
| | 0 |
| | 2,702 |
| | 2,702 |
|
Payables to parent and affiliates | 0 |
| | 20,413 |
| | 0 |
| | 20,413 |
| | 20,413 |
|
Other liabilities | 0 |
| | 58,357 |
| | 0 |
| | 58,357 |
| | 58,357 |
|
Total liabilities | $ | 0 |
| | $ | 260,711 |
| | $ | 40,349 |
| | $ | 301,060 |
| | $ | 302,025 |
|
| |
(1) | Carrying values presented herein differ from those in the Company’s Unaudited Interim Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
6. REINSURANCE
The Company participates in reinsurance with its affiliates Prudential Arizona Reinsurance Captive Company (“PARCC”), Prudential Arizona Reinsurance Term Company (“PAR Term”), Prudential Arizona Reinsurance Universal Company (“PAR U”), Prudential Term Reinsurance Company (“Term Re”) and Dryden Arizona Reinsurance Term Company (“DART”), its parent companies, Pruco Life and Prudential Insurance, as well as third parties. The reinsurance agreements provide risk diversification and additional capacity for future growth, limit the maximum net loss potential, manage statutory capital, and facilitate the Company's capital market hedging program. Life reinsurance is accomplished through various plans of reinsurance, primarily yearly renewable term and coinsurance. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. The Company believes a material reinsurance liability resulting from such inability of reinsurers to meet their obligations is unlikely.
Reserves related to reinsured long-duration contracts are accounted for using assumptions consistent with those used to account for the underlying contracts. Amounts recoverable from reinsurers for long-duration reinsurance arrangements are estimated in a manner consistent with the claim liabilities and policy benefits associated with the reinsured policies. Reinsurance premiums ceded for universal life products are accounted for as a reduction of policy charges and fee income. Reinsurance premiums ceded for term insurance products are accounted for as a reduction of premiums.
Realized investment gains and losses include the impact of reinsurance agreements, particularly reinsurance agreements involving living benefit guarantees. The Company has entered into a reinsurance agreement to transfer the risk related to living benefit guarantees on variable annuities to Prudential Insurance. These reinsurance agreements are derivatives and have been accounted for in the same manner as embedded derivatives and the changes in the fair value of these derivatives are recognized through “Realized investment gains (losses), net”. See Note 4 for additional information related to the accounting for embedded derivatives.
Reinsurance amounts included in the Company’s Unaudited Interim Statements of Financial Position as of March 31, 2019 and December 31, 2018 were as follows:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| (in thousands) |
Reinsurance recoverables | $ | 2,834,073 |
| | $ | 2,723,518 |
|
Policy loans | (17,394 | ) | | (17,297 | ) |
Deferred policy acquisition costs | (758,671 | ) | | (754,569 | ) |
Deferred sales inducements | (52,261 | ) | | (52,875 | ) |
Other assets | 16,472 |
| | 17,959 |
|
Other liabilities | 66,608 |
| | 65,225 |
|
The reinsurance recoverables by counterparty are broken out below:
|
| | | | | | | |
| March 31, 2019 | | December 31, 2018 |
| (in thousands) |
Prudential Insurance | $ | 1,012,459 |
| | $ | 924,847 |
|
PAR U | 941,152 |
| | 922,904 |
|
PARCC | 471,930 |
| | 480,627 |
|
PAR Term | 212,305 |
| | 205,972 |
|
Term Re | 165,481 |
| | 156,303 |
|
DART | 19,588 |
| | 13,367 |
|
Pruco Life | 9,786 |
| | 15,013 |
|
Unaffiliated | 1,372 |
| | 4,485 |
|
Total reinsurance recoverables | $ | 2,834,073 |
| | $ | 2,723,518 |
|
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Reinsurance amounts, included in the Company’s Unaudited Interim Statements of Operations and Comprehensive Income (Loss) for the three months ended March 31, were as follows:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
| (in thousands) |
Premiums: | | | |
Direct | $ | 63,014 |
| | $ | 59,374 |
|
Ceded | (59,676 | ) | | (56,877 | ) |
Net premiums | 3,338 |
| | 2,497 |
|
Policy charges and fee income: | | | |
Direct | 93,620 |
| | 102,562 |
|
Ceded | (73,771 | ) | | (77,748 | ) |
Net policy charges and fee income | 19,849 |
| | 24,814 |
|
Net investment income: | | | |
Direct | 18,909 |
| | 16,704 |
|
Ceded | (168 | ) | | (155 | ) |
Net investment income | 18,741 |
| | 16,549 |
|
Asset administration fees: | | | |
Direct | 8,879 |
| | 9,021 |
|
Ceded | (7,536 | ) | | (7,715 | ) |
Net asset administration fees | 1,343 |
| | 1,306 |
|
Realized investment gains (losses), net: | | | |
Direct | (62,843 | ) | | 133,138 |
|
Ceded | 56,733 |
| | (137,069 | ) |
Realized investment gains (losses), net | (6,110 | ) | | (3,931 | ) |
Policyholders’ benefits (including change in reserves): | | | |
Direct | 72,028 |
| | 73,168 |
|
Ceded(1) | (62,051 | ) | | (64,616 | ) |
Net policyholders’ benefits (including change in reserves) | 9,977 |
| | 8,552 |
|
Interest credited to policyholders’ account balances: | | | |
Direct | 15,217 |
| | 16,522 |
|
Ceded | (6,164 | ) | | (7,958 | ) |
Net interest credited to policyholders’ account balances | 9,053 |
| | 8,564 |
|
Reinsurance expense allowances and general and administrative expenses, net of capitalization and amortization | (39,502 | ) | | (44,486 | ) |
| |
(1) | "Policyholders’ benefits (including change in reserves) ceded" includes $0.9 million and (0.6) million of unaffiliated activity for the three months ended March 31, 2019 and 2018, respectively. |
The gross and net amounts of life insurance face amount in force as of March 31, 2019 and 2018 were as follows:
|
| | | | | | | |
| 2019 | | 2018 |
| (in thousands) |
Direct gross life insurance face amount in force | $ | 143,145,835 |
| | $ | 136,932,244 |
|
Reinsurance ceded | (130,509,208 | ) | | (124,758,204 | ) |
Net life insurance face amount in force | $ | 12,636,627 |
| | $ | 12,174,040 |
|
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Information regarding significant affiliated reinsurance agreements is described below.
Prudential Insurance
The Company has a yearly renewable term reinsurance agreement with Prudential Insurance and reinsures the majority of all mortality risks not otherwise reinsured. Effective July 1, 2017, this agreement was terminated for certain new business, primarily Universal Life business, and such business was reinsured to Pruco Life under a yearly renewable term reinsurance agreement. Effective April 1, 2016, the Company entered into a reinsurance agreement with Prudential Insurance to reinsure its variable annuity base contracts, along with the living benefit guarantees. This reinsurance agreement covers new and in force business and excludes business reinsured externally.
PAR U
Effective July 1, 2012, the Company reinsures an amount equal to 95% of all risks associated with Universal Protector policies having no-lapse guarantees as well as certain of its universal policies, excluding those policies that are subject to principles-based reserving.
PARCC
The Company reinsures 90% of the risks under its term life insurance policies with effective dates prior to January 1, 2010 through an automatic coinsurance agreement with PARCC.
PAR Term
The Company reinsures 95% of the risks under its term life insurance policies, with effective dates January 1, 2010 through December 31, 2013, through an automatic coinsurance agreement with PAR Term.
Term Re
The Company reinsures 95% of the risks under its term life insurance policies with effective dates on or after January 1, 2014 through December 31, 2017, through an automatic coinsurance agreement with Term Re.
Pruco Life
Effective July 1, 2017, the Company entered into a yearly renewable term reinsurance agreement with Pruco Life for new business, primarily covering Universal Life policies. Under this agreement the majority of all mortality risk is ceded to Pruco Life. The Company also reinsures certain Corporate Owned Life Insurance (“COLI”) policies with Pruco Life.
DART
Effective January 1, 2018, the Company entered into an automatic coinsurance agreement with DART to reinsure an amount equal to 95% of the risks associated with its term life insurance policies with effective dates on or after January 1, 2018.
7. INCOME TAXES
The Company uses a full year projected effective tax rate approach to calculate year-to-date taxes. In addition, certain items impacting total income tax expense are recorded in the periods in which they occur. The projected effective tax rate is the ratio of projected “Total income tax expense (benefit)” divided by projected “Income (loss) from operations before income taxes". The interim period tax expense (or benefit) is the difference between the year-to-date income tax provision and the amounts reported for the previous interim periods of the fiscal year.
The Company's income tax provision amounted to an income tax expense of $0.6 million, or 5.19% of income (loss) from operations before income taxes in the first three months of 2019, compared to $0.7 million, or 6.94%, in the first three months of 2018. The Company’s current and prior effective tax rates differed from the U.S. statutory tax rate of 21% primarily due to non-taxable investment income and tax credits.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
8. EQUITY
Accumulated Other Comprehensive Income (Loss)
AOCI represents the cumulative OCI items that are reported separate from net income and detailed on the Statements of Comprehensive Income. The balance of and changes in each component of AOCI as of and for the three months ended March 31, 2019 and 2018, are as follows:
|
| | | | | | | | | | | |
| Accumulated Other Comprehensive Income (Loss) |
| Foreign Currency Translation Adjustment | | Net Unrealized Investment Gains (Losses)(1) | | Total Accumulated Other Comprehensive Income (Loss) |
| (in thousands) |
Balance, December 31, 2018 | $ | (989 | ) | | $ | (13,378 | ) | | $ | (14,367 | ) |
Change in OCI before reclassifications | 0 |
| | 43,324 |
| | 43,324 |
|
Amounts reclassified from AOCI | 0 |
| | 3,274 |
| | 3,274 |
|
Income tax benefit (expense) | 0 |
| | (9,786 | ) | | (9,786 | ) |
Balance, March 31, 2019 | $ | (989 | ) | | $ | 23,434 |
| | $ | 22,445 |
|
|
| | | | | | | | | | | |
| Accumulated Other Comprehensive Income (Loss) |
| Foreign Currency Translation Adjustment | | Net Unrealized Investment Gains (Losses)(1) | | Total Accumulated Other Comprehensive Income (Loss) |
| (in thousands) |
Balance, December 31, 2017 | $ | (42 | ) | | $ | 34,372 |
| | $ | 34,330 |
|
Change in OCI before reclassifications | (235 | ) | | (37,213 | ) | | (37,448 | ) |
Amounts reclassified from AOCI | 0 |
| | 652 |
| | 652 |
|
Income tax benefit (expense) | 49 |
| | 7,679 |
| | 7,728 |
|
Cumulative effect of adoption of ASU 2016-01 | 0 |
| | (175 | ) | | (175 | ) |
Cumulative effect of adoption of ASU 2018-02 | (8 | ) | | 5,901 |
| | 5,893 |
|
Balance, March 31, 2018 | $ | (236 | ) | | $ | 11,216 |
| | $ | 10,980 |
|
| |
(1) | Includes cash flow hedges of $2 million and $2 million as of March 31, 2019 and December 31, 2018, respectively, and $(9) million and $(5) million as of March 31, 2018 and December 31, 2017, respectively. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Reclassifications out of Accumulated Other Comprehensive Income (Loss)
|
| | | | | | | |
| Three Months Ended March 31, |
| 2019 | | 2018 |
| (in thousands) |
Amounts reclassified from AOCI (1)(2): | | | |
Net unrealized investment gains (losses): | | | |
Cash flow hedges - Currency/ Interest rate(3) | $ | (179 | ) | | $ | (654 | ) |
Net unrealized investment gains (losses) on available-for-sale securities | (3,095 | ) | | 2 |
|
Total net unrealized investment gains (losses)(4) | (3,274 | ) | | (652 | ) |
Total reclassifications for the period | $ | (3,274 | ) | | $ | (652 | ) |
| |
(1) | All amounts are shown before tax. |
| |
(2) | Positive amounts indicate gains/ benefits reclassified out of AOCI. Negative amounts indicate losses/ costs reclassified out of AOCI. |
| |
(3) | See Note 4 for additional information on cash flow hedges. |
| |
(4) | See table below for additional information on unrealized investment gains (losses), including the impact on deferred policy acquisition and other costs, future policy benefits, policyholders’ account balances and other liabilities. |
Net Unrealized Investment Gains (Losses)
Net unrealized investment gains (losses) on securities classified as available-for-sale and certain other invested assets and other assets are included in the Company’s Unaudited Interim Statements of Financial Position as a component of AOCI. Changes in these amounts include reclassification adjustments to exclude from OCI those items that are included as part of “Net income” for a period that had been part of OCI in earlier periods. The amounts for the periods indicated below, split between amounts related to fixed maturity securities on which an OTTI loss has been recognized, and all other net unrealized investment gains (losses), are as follows:
Net Unrealized Investment Gains (Losses) on Fixed Maturity Securities on which an OTTI loss has been recognized
|
| | | | | | | | | | | | | | | | | | | |
| Net Unrealized Gains (Losses) on Investments | | Deferred Policy Acquisition Costs and Other Costs(1) | | Future Policy Benefits, Policyholders' Account Balances and Other Liabilities(2) | | Deferred Income Tax (Liability) Benefit | | Accumulated Other Comprehensive Income (Loss) Related To Net Unrealized Investment Gains (Losses) |
| (in thousands) |
Balance, December 31, 2018 | $ | 143 |
| | $ | (54 | ) | | $ | 42 |
| | $ | (54 | ) | | $ | 77 |
|
Net investment gains (losses) on investments arising during the period | 2 |
| | 0 |
| | 0 |
| | 0 |
| | 2 |
|
Reclassification adjustment for (gains) losses included in net income | (60 | ) | | 0 |
| | 0 |
| | 13 |
| | (47 | ) |
Reclassification adjustment for OTTI (gains) losses excluded from net income | (207 | ) | | 0 |
| | 0 |
| | 43 |
| | (164 | ) |
Impact of net unrealized investment (gains) losses on deferred policy acquisition costs and other costs | 0 |
| | 63 |
| | 0 |
| | (13 | ) | | 50 |
|
Impact of net unrealized investment (gains) losses on future policy benefits, policyholders' account balances and other liabilities | 0 |
| | 0 |
| | (47 | ) | | 10 |
| | (37 | ) |
Balance, March 31, 2019 | $ | (122 | ) | | $ | 9 |
| | $ | (5 | ) | | $ | (1 | ) | | $ | (119 | ) |
| |
(1) | "Other costs" primarily includes reinsurance recoverables and deferred reinsurance losses. |
| |
(2) | "Other liabilities" primarily includes reinsurance payables. |
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
All Other Net Unrealized Investment Gains (Losses) in AOCI
|
| | | | | | | | | | | | | | | | | | | |
| Net Unrealized Gains (Losses) on Investments(2) | | Deferred Policy Acquisition Costs and Other Costs(3) | | Future Policy Benefits, Policyholders' Account Balances and Other Liabilities(4) | | Deferred Income Tax (Liability) Benefit | | Accumulated Other Comprehensive Income (Loss) Related To Net Unrealized Investment Gains (Losses) |
| (in thousands) |
Balance, December 31, 2018 | $ | (17,764 | ) | | $ | 3,169 |
| | $ | (2,472 | ) | | $ | 3,612 |
| | $ | (13,455 | ) |
Net investment gains (losses) on investments arising during the period | 44,896 |
| | 0 |
| | 0 |
| | (9,429 | ) | | 35,467 |
|
Reclassification adjustment for (gains) losses included in net income | 3,334 |
| | 0 |
| | 0 |
| | (700 | ) | | 2,634 |
|
Reclassification adjustment for OTTI (gains) losses excluded from net income(1) | 207 |
| | 0 |
| | 0 |
| | (43 | ) | | 164 |
|
Impact of net unrealized investment (gains) losses on deferred policy acquisition costs and other costs | 0 |
| | 3,839 |
| | 0 |
| | (807 | ) | | 3,032 |
|
Impact of net unrealized investment (gains) losses on future policy benefits, policyholders' account balances and other liabilities | 0 |
| | 0 |
| | (5,429 | ) | | 1,140 |
| | (4,289 | ) |
Balance, March 31, 2019 | $ | 30,673 |
| | $ | 7,008 |
| | $ | (7,901 | ) | | $ | (6,227 | ) | | $ | 23,553 |
|
| |
(1) | Represents "transfers out" related to the portion of OTTI losses recognized during the period that were not recognized in earnings for securities with no prior OTTI loss. |
| |
(2) | Includes cash flow hedges. See Note 4 for information on cash flow hedges. |
| |
(3) | "Other costs" primarily includes reinsurance recoverables and deferred reinsurance losses. |
| |
(4) | "Other liabilities" primarily includes reinsurance payables. |
9. RELATED PARTY TRANSACTIONS
The Company has extensive transactions and relationships with Prudential Insurance and other affiliates. Although we seek to ensure that these transactions and relationships are fair and reasonable, it is possible that the terms of these transactions are not the same as those that would result from transactions among unrelated parties.
Expense Charges and Allocations
Many of the Company’s expenses are allocations or charges from Prudential Insurance or other affiliates. These expenses can be grouped into general and administrative expenses and agency distribution expenses.
The Company’s general and administrative expenses are charged to the Company using allocation methodologies based on business production processes. Management believes that the methodology is reasonable and reflects costs incurred by Prudential Insurance to process transactions on behalf of the Company. The Company operates under service and lease agreements whereby services of officers and employees, supplies, use of equipment and office space are provided by Prudential Insurance. The Company reviews its allocation methodology periodically which it may adjust accordingly. General and administrative expenses include allocations of stock compensation expenses related to a stock-based awards program and a deferred compensation program issued by Prudential Financial. The expense charged to the Company for the stock-based awards program was $0.0 million for both the three months ended March 31, 2019 and 2018. The expense charged to the Company for the deferred compensation program was $0.3 million for both the three months ended March 31, 2019 and 2018.
The Company is charged for its share of employee benefit expenses. These expenses include costs for funded and non-funded contributory and non-contributory defined benefit pension plans. Some of these benefits are based on final earnings and length of service while others are based on an account balance, which takes into consideration age, service and earnings during a career. The Company’s share of net expense for the pension plans was $0.5 million and $0.7 million for the three months ended March 31, 2019 and 2018, respectively.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
The Company is also charged for its share of the costs associated with welfare plans issued by Prudential Insurance. These expenses include costs related to medical, dental, life insurance and disability. The Company's share of net expense for the welfare plans was $0.7 million and $0.9 million for the three months ended March 31, 2019 and 2018, respectively.
Prudential Insurance sponsors voluntary savings plans for its employee 401(k) plans. The plans provide for salary reduction contributions by employees and matching contributions by the Company of up to 4% of annual salary. The Company’s expense for its share of the voluntary savings plan was $0.2 million and $0.3 million for the three months ended March 31, 2019 and 2018 respectively.
The Company is charged distribution expenses from Prudential Insurance’s agency network for both its domestic life and annuity products through a transfer pricing agreement, which is intended to reflect a market-based pricing arrangement.
The Company pays commissions and certain other fees to Prudential Annuities Distributors, Inc. (“PAD”) in consideration for PAD’s marketing and underwriting of the Company’s annuity products. Commissions and fees are paid by PAD to broker-dealers who sell the Company’s annuity products. Commissions and fees paid by the Company to PAD were $19 million and $17 million for the three months ended March 31, 2019 and 2018, respectively.
The Company is charged for its share of corporate expenses incurred by Prudential Financial to benefit its businesses, such as advertising, executive oversight, external affairs and philanthropic activity. The Company’s share of corporate expenses was $2 million for both the three months ended March 31, 2019 and 2018.
Corporate Owned Life Insurance
The Company has sold three Corporate-Owned Life Insurance ("COLI") policies to Prudential Insurance and one to Prudential Financial. The cash surrender value included in separate accounts for these COLI policies was $2,521 million at March 31, 2019 and $2,239 million at December 31, 2018. Fees related to these COLI policies were $7 million for both the three months ended March 31, 2019 and 2018. The Company retains 10% of the mortality risk associated with these COLI policies up to $0.1 million per individual policy.
Affiliated Investment Management Expenses
In accordance with an agreement with PGIM, Inc. (“PGIM”), the Company pays investment management expenses to PGIM who acts as investment manager to certain Company general account and separate account assets. Investment management expenses paid to PGIM related to this agreement were $0.5 million and $0.6 million for the three months ended March 31, 2019 and 2018, respectively. These expenses are recorded as “Net investment income” in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss).
Derivative Trades
In its ordinary course of business, the Company enters into OTC derivative contracts with an affiliate, PGF. For these OTC derivative contracts, PGF has a substantially equal and offsetting position with an external counterparty. See Note 4 for additional information.
Joint Ventures
The Company has made investments in joint ventures with certain subsidiaries of Prudential Financial. "Other invested assets" includes $35 million and $33 million as of March 31, 2019 and December 31, 2018, respectively. "Net investment income" related to these ventures includes a gain of $1.4 million and $0.2 million for the three months ended March 31, 2019 and 2018, respectively.
Affiliated Asset Administration Fee Income
The Company has a revenue sharing agreement with AST Investment Services, Inc. ("ASTISI") and PGIM Investments LLC ("PGIM Investments") whereby the Company receives fee income based on policyholders' separate account balances invested in the Advanced Series Trust. Income received from ASTISI and PGIM Investments related to this agreement was $8 million for both the three months ended March 31, 2019 and 2018. These revenues are recorded as “Asset administration fees” in the Company's Unaudited Interim Statements of Operations and Comprehensive Income (Loss).
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
The Company has a revenue sharing agreement with PGIM Investments, whereby the Company receives fee income based on policyholders' separate account balances invested in The Prudential Series Fund. Income received from PGIM Investments related to this agreement was $1 million for both the three months ended March 31, 2019 and 2018. These revenues are recorded as “Asset administration fees” in the Company’s Unaudited Interim Statements of Operations and Comprehensive Income (Loss).
Affiliated Notes Receivable
Affiliated notes receivable included in “Receivables from parent and affiliates” at March 31, 2019 and December 31, 2018 were as follows:
|
| | | | | | | | | | | | | | | | |
| Maturity Dates | | Interest Rates | | March 31, 2019 | | December 31, 2018 |
| | | | | | | | | (in thousands) |
U.S. dollar floating rate notes | 2028 | | 4.02% | - | 4.23 | % | | $ | 0 |
| | $ | 6,001 |
|
U.S. dollar fixed rate notes | 2026 | - | 2027 | | 0.00% | - | 14.85 | % | | 2,762 |
| | 2,823 |
|
Total notes receivable - affiliated(1) | | | | | | | | | $ | 2,762 |
| | $ | 8,824 |
|
| |
(1) | All notes receivable may be called for prepayment prior to the respective maturity dates under specified circumstances. |
The affiliated notes receivable shown above are classified as available-for-sale securities and other trading assets carried at fair value. The Company monitors the internal and external credit ratings of these loans and loan performance. The Company also considers any guarantees made by Prudential Insurance for loans due from affiliates.
Accrued interest receivable related to these loans was $0.0 million and $0.1 million at March 31, 2019 and December 31, 2018, respectively, and is included in “Other assets”. Revenues related to these assets were $0.0 million and $0.1 million for the three months ended March 31, 2019 and 2018, respectively, and are included in “Other income”.
Affiliated Asset Transfers
The Company participates in affiliated asset trades with parent and sister companies. Book and market value differences for trades with a parent and sister are recognized within "Additional paid-in capital" (“APIC”) and "Realized investment gains (losses), net", respectively. There were no affiliated asset trades for the three months ended March 31, 2019. The table below shows affiliated asset trades for the year ended December 31, 2018.
|
| | | | | | | | | | | | | | | | | | | | | | |
Affiliate | | Date | | Transaction | | Security Type | | Fair Value | | Book Value | | APIC, Net of Tax Increase/(Decrease) | | Realized Investment Gain (Loss) |
| | | | | | | | (in thousands) |
Gibraltar Universal Life Reinsurance Company | | May 2018 | | Purchase | | Fixed Maturities | | $ | 17,904 |
| | $ | 17,904 |
| | $ | 0 |
| | $ | 0 |
|
Debt Agreements
The Company is authorized to borrow funds up to $200 million from affiliates to meet its capital and other funding needs. As of March 31, 2019 and December 31, 2018, there was no debt outstanding.
The total interest expense to the Company related to loans payable to affiliates was $0.0 million for both the three months ended March 31, 2019 and 2018.
Contributed Capital and Dividends
Through March 2019, the Company did not receive any capital contributions. In March 2018, the Company received a capital contribution in the amount of $1 million from Pruco Life.
Through March 2019, the Company did not pay any dividends. In 2018, the Company did not pay any dividends.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
Reinsurance with Affiliates
As discussed in Note 6, the Company participates in reinsurance transactions with certain affiliates.
10. COMMITMENTS AND CONTINGENT LIABILITIES
Commitments
The Company has made commitments to fund commercial mortgage loans. As of March 31, 2019, there were $7 million outstanding commitments to fund commercial loans, and none as of December 31, 2018. The Company has made commitments to purchase or fund investments, mostly private fixed maturities. As of March 31, 2019 and December 31, 2018, $45 million and $41 million, respectively, of these commitments were outstanding.
Contingent Liabilities
On an ongoing basis, the Company and its regulators review its operations including, but not limited to, sales and other customer interface procedures and practices, and procedures for meeting obligations to our customers and other parties. These reviews may result in the modification or enhancement of processes or the imposition of other action plans, including concerning management oversight, sales and other customer interface procedures and practices, and the timing or computation of payments to customers and other parties. In certain cases, if appropriate, the Company may offer customers or other parties remediation and may incur charges, including the cost of such remediation, administrative costs and regulatory fines.
The Company is subject to the laws and regulations of states and other jurisdictions concerning the identification, reporting and escheatment of unclaimed or abandoned funds, and is subject to audit and examination for compliance with these requirements.
It is possible that the results of operations or the cash flows of the Company in a particular quarterly or annual period could be materially affected as a result of payments in connection with the matters discussed above or other matters depending, in part, upon the results of operations or cash flows for such period. Management believes, however, that ultimate payments in connection with these matters, after consideration of applicable reserves and rights to indemnification, should not have a material adverse effect on the Company’s financial position.
Litigation and Regulatory Matters
The Company is subject to legal and regulatory actions in the ordinary course of its business. Pending legal and regulatory actions include proceedings specific to the Company and proceedings generally applicable to business practices in the industry in which it operates. The Company is subject to class action lawsuits and other litigation involving a variety of issues and allegations involving sales practices, claims payments and procedures, premium charges, policy servicing and breach of fiduciary duty to customers. The Company is also subject to litigation arising out of its general business activities, such as its investments, contracts, leases and labor and employment relationships, including claims of discrimination and harassment, and could be exposed to claims or litigation concerning certain business or process patents. In addition, the Company, along with other participants in the businesses in which it engages, may be subject from time to time to investigations, examinations and inquiries, in some cases industry-wide, concerning issues or matters upon which such regulators have determined to focus. In some of the Company’s pending legal and regulatory actions, parties are seeking large and/or indeterminate amounts, including punitive or exemplary damages. The outcome of litigation or a regulatory matter, and the amount or range of potential loss at any particular time, is often inherently uncertain.
The Company establishes accruals for litigation and regulatory matters when it is probable that a loss has been incurred and the amount of that loss can be reasonably estimated. For litigation and regulatory matters where a loss may be reasonably possible, but not probable, or is probable but not reasonably estimable, no accrual is established, but the matter, if material, is disclosed. The Company estimates that as of March 31, 2019, the aggregate range of reasonably possible losses in excess of accruals established for those litigation and regulatory matters for which such an estimate currently can be made is less than $10 million. This estimate is not an indication of expected loss, if any, or the Company's maximum possible loss exposure on such matters. The Company reviews relevant information with respect to its litigation and regulatory matters on a quarterly and annual basis and updates its accruals, disclosures and estimates of reasonably possible loss based on such reviews.
Table of Contents |
|
PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY |
Notes to Unaudited Interim Financial Statements—(Continued) |
The following discussion of litigation and regulatory matters provides an update of those matters discussed in Note 14 to the Company’s Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, and should be read in conjunction with the complete descriptions provided in the Form 10-K.
Securities Lending and Foreign Tax Reclaim Matter
In 2016, Prudential Financial self-reported to the SEC and the U.S. Department of Labor ("DOL"), and notified other regulators, that in some cases it failed to maximize securities lending income for the benefit of certain separate account investments due to a long-standing restriction benefiting Prudential Financial that limited the availability of loanable securities. Prudential Financial has removed the restriction and implemented a remediation plan for the benefit of customers. As part of Prudential Financial’s review of this matter, in 2018 it further self-reported to the SEC, and notified other regulators, that in some cases it failed to timely process foreign tax reclaims for the separate account investments. Prudential Financial has corrected the foreign tax reclaim process and has implemented a remediation plan for the benefit of customers.
The DOL’s review of the securities lending matter is closed. Prudential Financial is cooperating with the SEC in its review of the securities lending and foreign tax reclaim matters (which includes a review of the remediation plans) and has entered into discussions with the SEC staff regarding a possible settlement of both matters that would potentially involve charges under the Investment Advisers Act and financial remedies. Prudential Financial cannot predict the outcome of the discussions with the SEC regarding these matters.
Summary
The Company’s litigation and regulatory matters are subject to many uncertainties, and given their complexity and scope, their outcome cannot be predicted. It is possible that the Company’s results of operations or cash flows in a particular quarterly or annual period could be materially affected by an ultimate unfavorable resolution of pending litigation and regulatory matters depending, in part, upon the results of operations or cash flows for such period. In light of the unpredictability of the Company’s litigation and regulatory matters, it is also possible that in certain cases an ultimate unfavorable resolution of one or more pending litigation or regulatory matters could have a material adverse effect on the Company’s financial position. Management believes, however, that, based on information currently known to it, the ultimate outcome of all pending litigation and regulatory matters, after consideration of applicable reserves and rights to indemnification, is not likely to have a material adverse effect on the Company’s financial position.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) addresses the financial condition of Pruco Life Insurance Company of New Jersey, or the “Company,” as of March 31, 2019, compared with December 31, 2018, and its results of operations for the three months ended March 31, 2019 and 2018. You should read the following analysis of our financial condition and results of operations in conjunction with the MD&A, the “Risk Factors” section, and the audited Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, as well as the statements under “Forward-Looking Statements” and the Unaudited Interim Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.
Overview
The Company is licensed to sell variable and fixed annuities, universal life insurance, variable life insurance and term life insurance in New Jersey and New York only and sells such products primarily through affiliated and unaffiliated distributors.
Regulatory Developments
For information on the potential impacts of regulation on the Company see “Business—Regulation” and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018.
Impact of a Low Interest Rate Environment
As a financial services company, market interest rates are a key driver of our results of operations and financial condition. Changes in interest rates can affect our results of operations and/or our financial condition in several ways, including favorable or adverse impacts to:
• investment-related activity, including: investment income returns, net interest margins, net investment spread
results, new money rates, mortgage loan prepayments and bond redemptions;
• insurance reserve levels, market experience true-ups and amortization of deferred policy acquisition costs (“DAC”);
• customer account values, including their impact on fee income;
• product offerings, design features, crediting rates and sales mix; and
• policyholder behavior, including surrender or withdrawal activity.
Interest rates in the U.S. have experienced a period of historically low levels in large part due to Federal Reserve efforts to assist with the economic recovery subsequent to the financial crisis of 2008. While market conditions and events make uncertain the timing, amount and impact of any monetary policy decisions by the Federal Reserve, a trend of rising interest rates may enhance our reinvestment yields, primarily for our investments in fixed maturity securities and commercial mortgage loans. As interest rates rise, our reinvestment yield may approach or exceed the overall portfolio yield. Conversely, if interest rates were to decline, our reinvestment yield may fall below our overall portfolio yield, resulting in an unfavorable impact to earnings.
For more information on interest rate risks, see “Risk Factors—Market Risk” included in our Annual Report on Form 10-K for the year ended December 31, 2018.
Revenues and Expenses
The Company earns revenues principally from insurance premiums, mortality and expense fees, asset administration fees from insurance and investment products, and from net investment income on the investment of general account and other funds. The Company receives premiums primarily from the sale of individual life insurance and annuity products. The Company earns mortality and expense fees, and asset administration fees, primarily from the sale and servicing of universal life insurance and separate account products including variable life insurance and variable annuities. The Company’s operating expenses principally consist of insurance benefits provided and reserves established for anticipated future insurance benefits, general business expenses, reinsurance premiums, commissions and other costs of selling and servicing the various products sold and interest credited on general account liabilities.
Profitability
The Company’s profitability depends principally on its ability to price our insurance and annuity products at a level that enables us to earn a margin over the costs associated with providing benefits and administering those products. Profitability also depends on, among other items, our actuarial and policyholder behavior experience on insurance and annuity products, our ability to attract and retain customer assets, generate and maintain favorable investment results, and manage expenses.
See “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 for a discussion of risks that have materially affected and may affect in the future the Company’s business, results of operations or financial condition, or cause the Company’s actual results to differ materially from those expected or those expressed in any forward-looking statements made by or on behalf of the Company.
Accounting Policies & Pronouncements
Application of Critical Accounting Estimates
The preparation of financial statements in conformity with U.S. GAAP requires the application of accounting policies that often involve a significant degree of judgment. Management reviews estimates and assumptions used in the preparation of financial statements on an ongoing basis. If management determines that modifications in assumptions and estimates are appropriate given current facts and circumstances, the Company’s results of operations and financial position as reported in the Unaudited Interim Financial Statements could change significantly.
Management believes the accounting policies relating to the following areas are most dependent on the application of estimates and assumptions and require management’s most difficult, subjective, or complex judgments:
| |
• | DAC and other costs, including deferred sales inducements (“DSI”); |
| |
• | Policyholder liabilities; |
| |
• | Valuation of investments, including derivatives, and the recognition of other-than-temporary impairments ("OTTI"); |
| |
• | Reinsurance recoverables; |
| |
• | Reserves for contingencies, including reserves for losses in connection with unresolved legal matters. |
Market Performance - Equity and Interest Assumptions
DAC and other costs associated with the variable and universal life policies and the variable and fixed annuity contracts are generally amortized over the expected lives of these policies in proportion to total gross profits. Total gross profits include both actual gross profits and estimates of gross profits for future periods. The quarterly adjustments for market performance reflect the impact of changes to our estimate of total gross profits to reflect actual fund performance and market conditions. A significant portion of gross profits for our variable annuity contracts and, to a lesser degree, our variable life policies are dependent upon the total rate of return on assets held in separate account investment options. This rate of return influences the fees we earn, costs we incur associated with the guaranteed minimum death and guaranteed minimum income benefit features related to our variable annuity contracts, as well as other sources of profit. Returns that are higher than our expectations for a given period produce higher than expected account balances, which increase the future fees we expect to earn and decrease the future costs we expect to incur associated with the guaranteed minimum death and guaranteed minimum income benefit features related to our variable annuity contracts. The opposite occurs when returns are lower than our expectations. The changes in future expected gross profits are used to recognize a cumulative adjustment to all prior periods’ amortization.
Furthermore, the calculation of the estimated liability for future policy benefits related to certain insurance products includes an estimate of associated revenues and expenses that are dependent on both historical market performance as well as estimates of market performance in the future. Similar to DAC and other costs described above, these liabilities are subject to quarterly adjustments for experience including market performance, in addition to annual adjustments resulting from our annual reviews of assumptions.
The weighted average rate of return assumptions used in developing estimated market returns consider many factors specific to each business, including asset durations, asset allocations and other factors. With regard to equity market assumptions, the near-term future rate of return assumption used in evaluating DAC, other costs and liabilities for future policy benefits for certain of our products, primarily domestic variable annuity and variable life insurance products is generally updated each quarter and is derived using a reversion to the mean approach, a common industry practice. Under this approach, we consider historical equity returns and adjust projected equity returns over an initial future period of five years (the “near-term”) so that equity returns converge to the long-term expected rate of return. If the near-term projected future rate of return is greater than our near-term maximum future rate of return of 15.0%, we use our maximum future rate of return. As of March 31, 2019, our variable annuities and variable life insurance businesses assume an 8.0% long-term equity expected rate of return and a 4.7% near-term mean reversion equity expected rate of return.
With regard to interest rate assumptions, we generally update the future interest rates used to project fixed income returns annually and in any quarter when interest rates vary significantly from these assumptions. As a result of our 2018 annual reviews and update of assumptions and other refinements, we kept our long-term expectation of the 10-year U.S. Treasury rate unchanged and continue to grade to 3.75% over ten years.
Adoption of New Accounting Pronouncements
See Note 2 to our Unaudited Interim Financial Statements for a discussion of newly adopted accounting pronouncements and accounting pronouncements issued but not yet adopted.
Changes in Financial Position
March 31, 2019 versus December 31, 2018
Total assets increased $1,432 million, from $18,120 million at December 31, 2018 to $19,552 million at March 31, 2019. Significant components were:
| |
• | Separate account assets increased $1,249 million primarily driven by favorable market performance and net inflows, partially offset by policy charges. |
| |
• | Reinsurance recoverables increased $111 million, primarily related to the annuity reinsured living benefit liabilities resulting from an increase in future expected benefit payments driven by credit spread tightening and decline in interest rates, partially offset by favorable equity market, as well as, by universal and term life business growth. |
| |
• | Total investments increased $111 million primarily driven by universal, term and variable life business growth and unrealized investment gains due to the decline in interest rates. |
Total liabilities increased $1,386 million, from $17,675 million at December 31, 2018 to $19,061 million at March 31, 2019. Significant components were:
| |
• | Separate account liabilities increased $1,249 million, corresponding to the increase in separate account assets described above. |
| |
• | Future policy benefits increased $113 million primarily related to the variable annuity living benefit liabilities and universal and term life business growth, as discussed above. |
| |
• | Policyholders’ account balances increased $35 million primarily driven by universal life business growth. |
Total equity increased $46 million from $445 million at December 31, 2018 to $491 million at March 31, 2019, primarily driven by unrealized investment gains due to the decline in interest rates and by after-tax income.
Results of Operations
Income (loss) from Operations before Income Taxes
2019 to 2018 Three Months Comparison
Excluding the impacts of the absence of the one-time internal corporate owned life insurance ("COLI") restructure in the individual life business, income from operations before income taxes remained relatively flat for the three months ended March 31, 2018 to the three months ended March 31, 2019.
Revenues, Benefits and Expenses
2019 to 2018 Three Months Comparison
Revenues decreased $4 million from $42 million for the three months ended March 31, 2018 to $38 million for the three months ended March 31, 2019. This decrease is primarily driven by a decrease in policy charges and fee income of $5 million primarily as a result of the absence of the one-time favorable impacts to unearned revenue reserves ("URR") related to the internal COLI restructure in the individual life business and a decrease in Other realized investment gains (losses) of $2 million primarily driven by realized losses on equity options due to the increase in the equity markets. This was partially offset by an increase in Net investment income of $2 million and in Other income of $1 million primarily driven by the business growth in the individual life business.
Benefits and expenses decreased $4 million from $31 million for the three months ended March 31, 2018 to $27 million for the three months ended March 31, 2019. This decrease is primarily driven by a $5 million decrease in Amortization of deferred policy acquisition costs primarily driven by the absence of the one-time unfavorable impact related to the internal COLI restructure in the individual life business. This was partially offset by a $1 million increase in policyholders' benefits primarily driven by the unfavorable mortality on term and variable life products in the individual life business.
Variable Annuity Risks and Risk Mitigants
The following is a summary of: (i) the risks associated with individual annuity products and (ii) our strategies in mitigating those risks, including any updates to those strategies since the previous year end. For a more detailed description of these items and their related accounting treatment, refer to the complete descriptions provided in our Annual Report on Form 10-K for the year ended December 31, 2018.
The primary risk exposures of our variable annuity contracts relate to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including capital markets assumptions such as equity market returns, interest rates, and market volatility, along with actuarial assumptions such as contractholder mortality, the timing and amount of annuitization and withdrawals, and contract lapses. For these risk exposures, achievement of our expected returns are subject to the risk that actual experience will differ from the assumptions used in the original pricing of these products. We currently manage our exposure to certain risks driven by fluctuations in the capital markets primarily through a combination of two strategies, described below including Product Design Features and an Asset Liability Management ("ALM") Strategy.
Product Design Features
A portion of the variable annuity contracts that we offer include an asset transfer feature. This feature is implemented at the contract level, and transfers assets between certain variable investment sub-accounts selected by the annuity contractholder and, depending on the benefit feature, a fixed-rate account in the general account or a bond fund sub-account within the separate account. The objective of the asset transfer feature is to reduce our exposure to equity market risk and market volatility. The asset transfer feature associated with currently-sold highest daily living benefit products uses a designated bond fund sub-account within the separate account. The transfers are based on a static mathematical formula used with the particular benefit which considers a number of factors, including, but not limited to, the impact of investment performance on the contractholder’s total account value. Other product design features we utilize include, among others, asset allocation restrictions, minimum issuance age requirements and certain limitations on the amount of contractholder deposits, as well as a required minimum allocation to our general account for certain of our products. We have also introduced products that diversify our risk profile and have incorporated provisions in product design allowing frequent revisions of key pricing elements for certain products. In addition, there is diversity in our fee arrangements, as certain fees are primarily based on the benefit guarantee amount, the contractholder account value and/or premiums, which helps preserve certain revenue streams when market fluctuations cause account values to decline.
Asset Liability Management Strategy (including fixed income instruments and derivatives)
The current ALM strategy conducted within Prudential Insurance utilizes a combination of both traditional fixed income instruments and derivatives to defray potential claims associated with our variable annuity living benefit guarantees. The economic liability we manage with this ALM strategy consists of expected living benefit claims under less severe market conditions, which are managed using a traditional ALM strategy through the accumulation of fixed income and derivative instruments, and potential living benefit claims resulting from more severe market conditions, which are hedged using derivative instruments. For the portion of our ALM strategy executed with derivatives, Prudential Insurance enter into a range of exchange-traded, cleared, and over-the-counter (“OTC”) equity and interest rate derivatives, including, but not limited to: equity and treasury futures; total return and interest rate swaps; and options including equity options, swaptions, and floors and caps. Since the ALM strategy is conducted in Prudential Insurance, the results of the strategy do not directly impact the Company's results of operations or financial condition.
Income Taxes
For information regarding income taxes, see Note 7 to the Unaudited Interim Financial Statements.
Liquidity and Capital Resources
This section supplements and should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” included in our Annual Report on Form 10-K for the year ended December 31, 2018.
Overview
Liquidity refers to the ability to generate sufficient cash resources to meet the payment obligations of the Company. Capital refers to the long-term financial resources available to support the operations of our businesses, fund business growth, and provide a cushion to withstand adverse circumstances. Our ability to generate and maintain sufficient liquidity and capital depends on the profitability of our businesses, general economic conditions, our ability to borrow from affiliates and our access to the capital markets through affiliates as described herein.
Effective and prudent liquidity and capital management is a priority across the organization. Management monitors the liquidity of Prudential Financial, Prudential Insurance and the Company on a daily basis and projects borrowing and capital needs over a multi-year time horizon through our periodic planning process. We believe that cash flows from the sources of funds available to us are sufficient to satisfy the current liquidity requirements of Prudential Insurance, Prudential Financial and the Company, including under reasonably foreseeable stress scenarios. Prudential Financial has a capital management framework in place that governs the allocation of capital and approval of capital uses. Prudential Financial and the Company also employ a “Capital Protection Framework” to ensure the availability of capital resources to maintain adequate capitalization under various stress scenarios.
Our businesses are subject to comprehensive regulation and supervision by domestic and international regulators. These regulations currently include, or may include in the future requirements and limitations (many of which are the subject of ongoing rule-making) relating to capital, leverage, liquidity, stress-testing, overall risk management, credit exposure reporting and credit concentration. For information on these regulatory initiatives and their potential impact on us, see “Business—Regulation” and “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2018.
Capital
Our capital management framework is primarily based on statutory Risk-Based Capital ("RBC") measures. The RBC ratios are a primary measure of the capital adequacy of the Company. RBC is calculated based on statutory financial statements and risk formulas consistent with the practices of the National Association of Insurance Commissioners ("NAIC"). RBC considers, among other things, risks related to the type and quality of the invested assets, insurance-related risks associated with an insurer’s products and liabilities, interest rate risks and general business risks. RBC ratio calculations are intended to assist insurance regulators in measuring an insurer’s solvency and ability to pay future claims. The reporting of RBC measures is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities, but is available to the public. The Company’s capital levels substantially exceed the minimum level required by applicable insurance regulations. Our regulatory capital levels may be affected in the future by changes to the applicable regulations, proposals for which are currently under consideration by both domestic and international insurance regulators.
In 2018, the NAIC’s RBC framework was revised to reflect the reduction of the corporate tax rate from 35% to 21% under the Tax Act of 2017. The revisions apply to the calculation of our RBC ratio, beginning as of December 31, 2018. While there is no impact on our ability to pay claims, these revisions to the RBC framework have had the effect of increasing certain RBC factors, resulting in an overall decrease in insurers’ RBC ratios.
Capital Protection Framework
Prudential Financial and the Company employ a Capital Protection Framework ("Framework”) to ensure that sufficient capital resources are available to maintain adequate capitalization and competitive RBC ratio and solvency margins under various stress scenarios. The Framework incorporates the potential impacts from market related stresses, including equity markets, real estate, interest rates, and credit losses.
The Framework accommodates periodic volatility within ranges that are deemed acceptable, while also providing for additional potential sources of capital, including on-balance sheet capital, derivatives, and contingent sources of capital. We believe we currently have access to sufficient resources, either directly, or indirectly through Prudential Financial, to maintain adequate capitalization under a range of potential stress scenarios.
Affiliated Captive Reinsurance Companies
See “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources-Capital-Affiliated Captive Reinsurance Companies” included in our Annual Report on Form 10-K for the year ended December 31, 2018, for a discussion of our use of captive reinsurance companies.
Liquidity
Our liquidity is managed to ensure stable, reliable and cost-effective sources of cash flows to meet all of our obligations. Liquidity is provided by a variety of sources, as described more fully below, including portfolios of liquid assets. Our investment portfolios are integral to the overall liquidity of the Company. We use a projection process for cash flows from operations to ensure sufficient liquidity to meet projected cash outflows, including claims. The impact of Prudential Funding, LLC’s, or Prudential Funding, a wholly-owned subsidiary of Prudential Insurance, financing capacity on liquidity (as described below) is considered in the internal liquidity measures of the Company.
Liquidity is measured against internally-developed benchmarks that take into account the characteristics of both the asset portfolio and the liabilities that they support. We consider attributes of the various categories of liquid assets (for example, type of asset and credit quality) in calculating internal liquidity measures to evaluate our liquidity under various stress scenarios, including company-specific and market-wide events. We continue to believe that cash generated by ongoing operations and the liquidity profile of our assets provide sufficient liquidity under reasonably foreseeable stress scenarios.
Cash Flow
The principal sources of the Company’s liquidity are premiums and certain annuity considerations, investment and fee income, investment maturities and sales as well as internal borrowings. The principal uses of that liquidity include benefits, claims, and payments to policyholders and contractholders in connection with surrenders, withdrawals and net policy loan activity. Other uses of liquidity may include commissions, general and administrative expenses, purchases of investments, the payment of dividends to the parent company, hedging and reinsurance activity and payments in connection with financing activities.
Liquid Assets
Liquid assets include cash and cash equivalents, short-term investments, U.S. Treasury fixed maturities, fixed maturities that are not designated as held-to-maturity and public equity securities. As of March 31, 2019 and December 31, 2018 the Company had liquid assets of $(7) million and $(13) million, respectively. The portion of liquid assets comprised of cash and cash equivalents and short-term investments was $(61) million and $(68) million as of March 31, 2019 and December 31, 2018, respectively. As of March 31, 2019, $1,305 million, or 95%, of the fixed maturity investments in Company general account portfolios were rated high or highest quality based on NAIC or equivalent rating.
Term and Universal Life Reserve Financing
The Company uses affiliated captive reinsurance companies to finance the portion of the statutory reserves required to be held under Regulation XXX and Guideline AXXX that is considered to be non-economic. The financing arrangements involve the reinsurance of term and universal life business to our affiliated captive reinsurers and the issuance of surplus notes by those affiliated captives that are treated as capital for statutory purposes. These surplus notes are subordinated to policyholder obligations, and the payment of principal and interest on the surplus notes can only be made with prior insurance regulatory approval.
As of March 31, 2019, the affiliated captive reinsurance companies have entered into agreements with external counterparties providing for the issuance of up to an aggregate of $13.7 billion of surplus notes by our affiliated captive reinsurers in return for the receipt of credit-linked notes (“Credit-Linked Note Structures”), of which $11.4 billion of surplus notes was outstanding as of December 31, 2018. Under the agreements, the affiliated captive receives in exchange for the surplus notes one or more credit-linked notes issued by a special-purpose affiliate of the Company with an aggregate principal amount equal to the surplus notes outstanding. The affiliated captive holds the credit-linked notes as assets supporting Regulation XXX or Guideline AXXX non-economic reserves, as applicable. For more information on the Credit-Linked Note Structures, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Financing Activities" in the Annual Report on Form 10-K for the year ended December 31, 2018.
In addition, as of March 31, 2019, our affiliated captive reinsurance companies had outstanding an aggregate of $2.3 billion of debt issued for the purpose of financing Regulation XXX and Guideline AXXX non-economic reserves, of which approximately $0.6 billion relates to Regulation XXX reserves and approximately $1.7 billion relates to Guideline AXXX reserves. In addition, as of March 31, 2019, for purposes of financing Guideline AXXX reserves, our affiliated captives had outstanding approximately $4.0 billion of surplus notes that were issued to affiliates.
The Company has introduced updated versions of several products in its individual life product portfolio in conjunction with the requirement to adopt principle-based reserving by January 1, 2020. During 2017, the Company adopted principle-based reserving for its guaranteed universal life products and introduced updated versions of these products. The guaranteed universal life updated products support the principle-based statutory reserve level without the need for captive reserve financing. The Company is continuing to assess the impact of this new reserving approach on projected statutory reserve levels and product pricing for its remaining portfolio of individual life product offerings.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, our products and services, and the investment activities supporting them, generate exposure to market risk. The market risk incurred, and our strategies for managing this risk, vary by product. As of March 31, 2019, there have been no material changes in our economic exposure to market risk from December 31, 2018, a description of which may be found in our Annual Report on Form 10-K for the year ended December 31, 2018, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” filed with the SEC. See Item 1A, “Risk Factors” included in the Annual Report on Form 10-K for the year ended December 31, 2018, for a discussion of how difficult conditions in the financial markets and the economy generally may materially adversely affect our business and results of our operations.
Item 4. Controls and Procedures
In order to ensure that the information we must disclose in our filings with the SEC is recorded, processed, summarized, and reported on a timely basis, the Company’s management, including our Chief Executive Officer and Chief Financial Officer, have reviewed and evaluated the effectiveness of our disclosure controls and procedures, as defined in Securities Exchange Act of 1934, as amended (“Exchange Act”) Rule 13a-15(e), as of March 31, 2019. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2019, our disclosure controls and procedures were effective. No change in our internal control over financial reporting, as defined in Exchange Act Rule 13a-15(f), occurred during the quarter ended March 31, 2019, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
See Note 10 to the Unaudited Interim Financial Statements under “—Litigation and Regulatory Matters” for a description of certain pending litigation and regulatory matters affecting us, and certain risks to our business presented by such matters, which is incorporated herein by reference.
Item 1A. Risk Factors
You should carefully consider the risks described under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018. These risks could materially affect our business, results of operations or financial condition or cause our actual results to differ materially from those expected or those expressed in any forward-looking statements made by or on behalf of the Company. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under “Forward-Looking Statements” above and the risks of our business described elsewhere in this Quarterly Report on Form 10-Q.
Item 6. Exhibits
|
|
EXHIBIT INDEX |
|
|
|
|
|
|
|
|
|
101.INS - XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
|
101.SCH - XBRL Taxonomy Extension Schema Document. |
|
101.CAL - XBRL Taxonomy Extension Calculation Linkbase Document |
|
101.LAB - XBRL Taxonomy Extension Label Linkbase Document |
|
101.PRE - XBRL Taxonomy Extension Presentation Linkbase Document |
|
101.DEF - XBRL Taxonomy Extension Definition Linkbase Document |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
| | | |
| Pruco Life Insurance Company of New Jersey |
| | |
| By: | | /s/ John Chieffo |
| Name: | | John Chieffo |
| | | Vice President and Chief Financial Officer |
| | | (Authorized Signatory and Principal Financial Officer) |
Date: May 9, 2019